| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | glycogen phosphorylase activity | 5.44e-07 | 3 | 164 | 3 | GO:0008184 | |
| GeneOntologyMolecularFunction | 1,4-alpha-oligoglucan phosphorylase activity | 5.37e-06 | 5 | 164 | 3 | GO:0004645 | |
| GeneOntologyMolecularFunction | ATP-dependent protein disaggregase activity | 1.07e-05 | 6 | 164 | 3 | GO:0140545 | |
| GeneOntologyMolecularFunction | C3HC4-type RING finger domain binding | 1.07e-05 | 6 | 164 | 3 | GO:0055131 | |
| GeneOntologyMolecularFunction | antioxidant activity | 1.53e-05 | 97 | 164 | 7 | GO:0016209 | |
| GeneOntologyMolecularFunction | peroxidase activity | 1.55e-05 | 65 | 164 | 6 | GO:0004601 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on peroxide as acceptor | 1.85e-05 | 67 | 164 | 6 | GO:0016684 | |
| GeneOntologyMolecularFunction | phosphatidylinositol phospholipase C activity | 5.70e-05 | 26 | 164 | 4 | GO:0004435 | |
| GeneOntologyMolecularFunction | glutathione peroxidase activity | 7.70e-05 | 28 | 164 | 4 | GO:0004602 | |
| GeneOntologyMolecularFunction | phospholipase C activity | 8.88e-05 | 29 | 164 | 4 | GO:0004629 | |
| GeneOntologyMolecularFunction | phosphoric diester hydrolase activity | 1.49e-04 | 97 | 164 | 6 | GO:0008081 | |
| GeneOntologyMolecularFunction | denatured protein binding | 2.00e-04 | 3 | 164 | 2 | GO:0031249 | |
| GeneOntologyMolecularFunction | protein-containing complex destabilizing activity | 2.30e-04 | 15 | 164 | 3 | GO:0140776 | |
| GeneOntologyMolecularFunction | ATP-dependent protein folding chaperone | 3.18e-04 | 40 | 164 | 4 | GO:0140662 | |
| GeneOntologyMolecularFunction | protein folding chaperone | 3.37e-04 | 73 | 164 | 5 | GO:0044183 | |
| GeneOntologyMolecularFunction | structural constituent of muscle | 4.22e-04 | 43 | 164 | 4 | GO:0008307 | |
| GeneOntologyMolecularFunction | double-stranded RNA binding | 4.58e-04 | 78 | 164 | 5 | GO:0003725 | |
| GeneOntologyMolecularFunction | calcium ion binding | MASP1 PADI4 CALR3 ENPP2 ANXA6 EFHD2 CLSTN1 EHD4 EFHC1 PLCB1 C1S PLCB3 PLCG1 FER1L5 CDH2 PADI3 | 4.61e-04 | 749 | 164 | 16 | GO:0005509 |
| GeneOntologyMolecularFunction | DNA endonuclease activity | 4.61e-04 | 44 | 164 | 4 | GO:0004520 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYH3 HYOU1 KIF1A SMARCAL1 PSMC2 UBA2 ACSS2 DICER1 ABCB1 MDN1 GET3 HSPA1A HSPA1B HSPA8 | 5.58e-04 | 614 | 164 | 14 | GO:0140657 |
| GeneOntologyMolecularFunction | unfolded protein binding | 6.13e-04 | 126 | 164 | 6 | GO:0051082 | |
| GeneOntologyMolecularFunction | AMP binding | 6.49e-04 | 21 | 164 | 3 | GO:0016208 | |
| GeneOntologyMolecularFunction | protein-arginine deiminase activity | 6.60e-04 | 5 | 164 | 2 | GO:0004668 | |
| GeneOntologyMolecularFunction | phosphodiesterase I activity | 6.60e-04 | 5 | 164 | 2 | GO:0004528 | |
| GeneOntologyMolecularFunction | death receptor agonist activity | 6.60e-04 | 5 | 164 | 2 | GO:0038177 | |
| GeneOntologyMolecularFunction | dinitrosyl-iron complex binding | 6.60e-04 | 5 | 164 | 2 | GO:0035731 | |
| GeneOntologyMolecularFunction | steroid delta-isomerase activity | 1.37e-03 | 7 | 164 | 2 | GO:0004769 | |
| GeneOntologyMolecularFunction | thioredoxin-dependent peroxiredoxin activity | 1.37e-03 | 7 | 164 | 2 | GO:0140824 | |
| GeneOntologyMolecularFunction | thioredoxin peroxidase activity | 1.37e-03 | 7 | 164 | 2 | GO:0008379 | |
| GeneOntologyMolecularFunction | glutathione transferase activity | 1.70e-03 | 29 | 164 | 3 | GO:0004364 | |
| GeneOntologyMolecularFunction | cadherin binding | 2.00e-03 | 339 | 164 | 9 | GO:0045296 | |
| GeneOntologyMolecularFunction | DNA nuclease activity | 2.25e-03 | 67 | 164 | 4 | GO:0004536 | |
| GeneOntologyMolecularFunction | peroxiredoxin activity | 2.32e-03 | 9 | 164 | 2 | GO:0051920 | |
| GeneOntologyMolecularFunction | phospholipase activity | 2.51e-03 | 114 | 164 | 5 | GO:0004620 | |
| GeneOntologyMolecularFunction | nuclear thyroid hormone receptor binding | 2.70e-03 | 34 | 164 | 3 | GO:0046966 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on ester bonds | ABHD17A MYH3 RBBP8 ENPP2 TATDN2 FBP2 PTEN DICER1 FAN1 ABHD17B N4BP2 PLCB1 PLCB3 PLCG1 PLCE1 | 2.73e-03 | 807 | 164 | 15 | GO:0016788 |
| GeneOntologyBiologicalProcess | phosphatidylinositol-mediated signaling | 9.95e-07 | 24 | 160 | 5 | GO:0048015 | |
| GeneOntologyBiologicalProcess | phosphatidylinositol catabolic process | 1.82e-06 | 4 | 160 | 3 | GO:0031161 | |
| GeneOntologyBiologicalProcess | cellular response to chemical stress | GPX8 STAU1 FANCD2 PRDX3 PDGFD PRDX1 VPS13A HSPA1A HSPA1B MAP2K7 TXNDC2 HSPA8 | 3.97e-05 | 377 | 160 | 12 | GO:0062197 |
| GeneOntologyBiologicalProcess | regulation of cytoplasmic pattern recognition receptor signaling pathway | 6.71e-05 | 129 | 160 | 7 | GO:0039531 | |
| GeneOntologyBiologicalProcess | phospholipid catabolic process | 1.02e-04 | 60 | 160 | 5 | GO:0009395 | |
| GeneOntologyBiologicalProcess | cellular catabolic process | NAALAD2 DNAJC16 ENPP2 GLYATL2 APOA2 MEFV GSTA3 RFPL4AL1 WASH6P PHKG2 SNX14 CROT RFPL4A PIK3C2A PRDX3 PRDX1 VPS13A GPR137B PLCB1 ATG4C PLCB3 PLCG1 HSPA8 | 1.04e-04 | 1253 | 160 | 23 | GO:0044248 |
| GeneOntologyBiologicalProcess | cellular response to oxidative stress | GPX8 STAU1 FANCD2 PRDX3 PDGFD PRDX1 HSPA1A HSPA1B TXNDC2 HSPA8 | 1.06e-04 | 295 | 160 | 10 | GO:0034599 |
| GeneOntologyCellularComponent | postsynapse | ABHD17A CACNB1 KIF1A TRIO PPP1R9A RPS7 PSD3 PSMC2 PTEN CLSTN1 DICER1 SNX14 ABHD17B PLCB1 DLG2 PLCB3 CDH2 HSPA8 SHISA6 | 4.10e-04 | 1018 | 164 | 19 | GO:0098794 |
| GeneOntologyCellularComponent | postsynaptic cytosol | 4.23e-04 | 45 | 164 | 4 | GO:0099524 | |
| GeneOntologyCellularComponent | lamellipodium | 4.77e-04 | 230 | 164 | 8 | GO:0030027 | |
| GeneOntologyCellularComponent | dendritic spine | 6.66e-04 | 242 | 164 | 8 | GO:0043197 | |
| GeneOntologyCellularComponent | inclusion body | 7.18e-04 | 90 | 164 | 5 | GO:0016234 | |
| GeneOntologyCellularComponent | glutamatergic synapse | PRUNE2 ABHD17A CACNB1 TRIO PPP1R9A PSD3 CLSTN1 DICER1 STAU1 ABHD17B PLCB1 DLG2 PLCG1 CDH2 HSPA8 SHISA6 | 7.18e-04 | 817 | 164 | 16 | GO:0098978 |
| GeneOntologyCellularComponent | neuron spine | 7.61e-04 | 247 | 164 | 8 | GO:0044309 | |
| GeneOntologyCellularComponent | postsynaptic density | ABHD17A PPP1R9A PSD3 PTEN CLSTN1 DICER1 ABHD17B DLG2 CDH2 HSPA8 SHISA6 | 8.93e-04 | 451 | 164 | 11 | GO:0014069 |
| GeneOntologyCellularComponent | postsynaptic recycling endosome membrane | 8.99e-04 | 6 | 164 | 2 | GO:0098944 | |
| GeneOntologyCellularComponent | BRCA1-C complex | 8.99e-04 | 6 | 164 | 2 | GO:0070533 | |
| GeneOntologyCellularComponent | myosin filament | 9.60e-04 | 25 | 164 | 3 | GO:0032982 | |
| GeneOntologyCellularComponent | blood microparticle | 9.73e-04 | 144 | 164 | 6 | GO:0072562 | |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 1.07e-03 | 201 | 164 | 7 | GO:0099634 | |
| GeneOntologyCellularComponent | postsynaptic endosome | 1.08e-03 | 26 | 164 | 3 | GO:0098845 | |
| GeneOntologyCellularComponent | asymmetric synapse | ABHD17A PPP1R9A PSD3 PTEN CLSTN1 DICER1 ABHD17B DLG2 CDH2 HSPA8 SHISA6 | 1.40e-03 | 477 | 164 | 11 | GO:0032279 |
| Domain | PHOSPHORYLASE | 6.41e-07 | 3 | 162 | 3 | PS00102 | |
| Domain | Glycg_phsphrylas | 6.41e-07 | 3 | 162 | 3 | IPR011833 | |
| Domain | Glyco_trans_35 | 6.41e-07 | 3 | 162 | 3 | IPR000811 | |
| Domain | Phosphorylase | 6.41e-07 | 3 | 162 | 3 | PF00343 | |
| Domain | - | 1.17e-06 | 122 | 162 | 9 | 3.40.30.10 | |
| Domain | Thioredoxin-like_fold | 2.27e-06 | 132 | 162 | 9 | IPR012336 | |
| Domain | EF-hand_like | 6.91e-06 | 15 | 162 | 4 | PF09279 | |
| Domain | PI-PLC-Y | 6.91e-06 | 15 | 162 | 4 | PF00387 | |
| Domain | PLCYc | 6.91e-06 | 15 | 162 | 4 | SM00149 | |
| Domain | PLipase_C_Pinositol-sp_Y | 6.91e-06 | 15 | 162 | 4 | IPR001711 | |
| Domain | PIPLC_Y_DOMAIN | 6.91e-06 | 15 | 162 | 4 | PS50008 | |
| Domain | PI-PLC_fam | 6.91e-06 | 15 | 162 | 4 | IPR001192 | |
| Domain | PLC_EF-hand-like | 6.91e-06 | 15 | 162 | 4 | IPR015359 | |
| Domain | HSP70 | 9.15e-06 | 16 | 162 | 4 | PF00012 | |
| Domain | GST_CTER | 1.05e-05 | 34 | 162 | 5 | PS50405 | |
| Domain | HSP70_2 | 1.19e-05 | 17 | 162 | 4 | PS00329 | |
| Domain | HSP70_1 | 1.19e-05 | 17 | 162 | 4 | PS00297 | |
| Domain | HSP70_3 | 1.19e-05 | 17 | 162 | 4 | PS01036 | |
| Domain | PI-PLC-X | 1.52e-05 | 18 | 162 | 4 | PF00388 | |
| Domain | PLCXc | 1.52e-05 | 18 | 162 | 4 | SM00148 | |
| Domain | Hsp_70_fam | 1.52e-05 | 18 | 162 | 4 | IPR013126 | |
| Domain | PIPLC_X_DOMAIN | 1.91e-05 | 19 | 162 | 4 | PS50007 | |
| Domain | PLipase_C_PInositol-sp_X_dom | 1.91e-05 | 19 | 162 | 4 | IPR000909 | |
| Domain | Glutathione-S-Trfase_C-like | 2.09e-05 | 39 | 162 | 5 | IPR010987 | |
| Domain | - | 2.09e-05 | 39 | 162 | 5 | 1.20.1050.10 | |
| Domain | - | 5.99e-05 | 25 | 162 | 4 | 3.20.20.190 | |
| Domain | PLC-like_Pdiesterase_TIM-brl | 5.99e-05 | 25 | 162 | 4 | IPR017946 | |
| Domain | - | 1.33e-04 | 12 | 162 | 3 | 2.60.34.10 | |
| Domain | HSP70_peptide-bd | 1.33e-04 | 12 | 162 | 3 | IPR029047 | |
| Domain | RA | 1.43e-04 | 31 | 162 | 4 | SM00314 | |
| Domain | - | 1.72e-04 | 13 | 162 | 3 | 1.20.1270.10 | |
| Domain | Heat_shock_70_CS | 1.72e-04 | 13 | 162 | 3 | IPR018181 | |
| Domain | HSP70_C | 1.72e-04 | 13 | 162 | 3 | IPR029048 | |
| Domain | PLC-beta_CS | 2.23e-04 | 3 | 162 | 2 | IPR009535 | |
| Domain | PLC-beta_C | 2.23e-04 | 3 | 162 | 2 | PF08703 | |
| Domain | PLC-beta_C | 2.23e-04 | 3 | 162 | 2 | IPR014815 | |
| Domain | DUF1154 | 2.23e-04 | 3 | 162 | 2 | PF06631 | |
| Domain | RA | 2.59e-04 | 36 | 162 | 4 | PF00788 | |
| Domain | RA | 2.88e-04 | 37 | 162 | 4 | PS50200 | |
| Domain | PH_dom-like | RANBP2 KIF1A TRIO PSD3 GRB7 PLEKHD1 RANBP3L PLCB1 PLCB3 PLCG1 APBB1IP PLCE1 | 3.51e-04 | 426 | 162 | 12 | IPR011993 |
| Domain | RA_dom | 3.91e-04 | 40 | 162 | 4 | IPR000159 | |
| Domain | Thioredoxin_domain | 4.30e-04 | 41 | 162 | 4 | IPR013766 | |
| Domain | PLC-beta | 4.44e-04 | 4 | 162 | 2 | IPR016280 | |
| Domain | Pept_S1A_C1r/C1S/mannan-bd | 4.44e-04 | 4 | 162 | 2 | IPR024175 | |
| Domain | - | 4.67e-04 | 261 | 162 | 9 | 1.10.238.10 | |
| Domain | PRY | 4.72e-04 | 42 | 162 | 4 | PF13765 | |
| Domain | THIOREDOXIN_2 | 5.17e-04 | 43 | 162 | 4 | PS51352 | |
| Domain | C2_dom | 5.78e-04 | 164 | 162 | 7 | IPR000008 | |
| Domain | SH3_1 | 5.78e-04 | 164 | 162 | 7 | PF00018 | |
| Domain | SH3 | 6.06e-04 | 216 | 162 | 8 | SM00326 | |
| Domain | SH3 | 6.06e-04 | 216 | 162 | 8 | PS50002 | |
| Domain | - | RANBP2 KIF1A TRIO PSD3 GRB7 PLEKHD1 RANBP3L PLCB3 PLCG1 APBB1IP PLCE1 | 6.26e-04 | 391 | 162 | 11 | 2.30.29.30 |
| Domain | SH3_domain | 6.83e-04 | 220 | 162 | 8 | IPR001452 | |
| Domain | 1-cysPrx_C | 7.35e-04 | 5 | 162 | 2 | PF10417 | |
| Domain | RDM_domain_RFPL | 7.35e-04 | 5 | 162 | 2 | IPR022723 | |
| Domain | GST_alpha | 7.35e-04 | 5 | 162 | 2 | IPR003080 | |
| Domain | PAD | 7.35e-04 | 5 | 162 | 2 | PF03068 | |
| Domain | PAD_N | 7.35e-04 | 5 | 162 | 2 | PF08526 | |
| Domain | PAD_M | 7.35e-04 | 5 | 162 | 2 | PF08527 | |
| Domain | PAD | 7.35e-04 | 5 | 162 | 2 | IPR004303 | |
| Domain | PAD_C | 7.35e-04 | 5 | 162 | 2 | IPR013530 | |
| Domain | Prot_Arg_deaminase_cen_dom | 7.35e-04 | 5 | 162 | 2 | IPR013733 | |
| Domain | PAD_N | 7.35e-04 | 5 | 162 | 2 | IPR013732 | |
| Domain | RDM | 7.35e-04 | 5 | 162 | 2 | PF11002 | |
| Domain | Peroxiredoxin_C | 7.35e-04 | 5 | 162 | 2 | IPR019479 | |
| Domain | PRY | 7.88e-04 | 48 | 162 | 4 | SM00589 | |
| Domain | PRY | 7.88e-04 | 48 | 162 | 4 | IPR006574 | |
| Domain | EF-hand-dom_pair | 9.19e-04 | 287 | 162 | 9 | IPR011992 | |
| Domain | C2 | 9.94e-04 | 131 | 162 | 6 | PF00168 | |
| Domain | CLIC | 1.10e-03 | 6 | 162 | 2 | IPR002946 | |
| Domain | C2 | 1.25e-03 | 137 | 162 | 6 | SM00239 | |
| Domain | C2 | 1.51e-03 | 142 | 162 | 6 | PS50004 | |
| Domain | AhpC/TSA | 1.53e-03 | 7 | 162 | 2 | IPR000866 | |
| Domain | AhpC-TSA | 1.53e-03 | 7 | 162 | 2 | PF00578 | |
| Domain | - | 1.61e-03 | 27 | 162 | 3 | 3.30.160.20 | |
| Domain | Glutathione_S-Trfase_N | 1.61e-03 | 27 | 162 | 3 | IPR004045 | |
| Domain | dsRBD_dom | 1.79e-03 | 28 | 162 | 3 | IPR014720 | |
| Domain | - | 1.86e-03 | 148 | 162 | 6 | 2.60.40.150 | |
| Domain | Hydrolase_4 | 2.59e-03 | 9 | 162 | 2 | IPR022742 | |
| Domain | Hydrolase_4 | 2.59e-03 | 9 | 162 | 2 | PF12146 | |
| Domain | SARAH | 2.59e-03 | 9 | 162 | 2 | PS50951 | |
| Domain | SARAH_dom | 2.59e-03 | 9 | 162 | 2 | IPR011524 | |
| Domain | Butyrophylin | 3.21e-03 | 70 | 162 | 4 | IPR003879 | |
| Domain | GST_C_3 | 3.21e-03 | 10 | 162 | 2 | PF14497 | |
| Domain | PH | 3.90e-03 | 229 | 162 | 7 | PF00169 | |
| Domain | EH | 3.91e-03 | 11 | 162 | 2 | PS50031 | |
| Domain | EH | 3.91e-03 | 11 | 162 | 2 | SM00027 | |
| Domain | EH_dom | 3.91e-03 | 11 | 162 | 2 | IPR000261 | |
| Domain | Ran_BP1 | 4.66e-03 | 12 | 162 | 2 | PF00638 | |
| Domain | RANBD1 | 4.66e-03 | 12 | 162 | 2 | PS50196 | |
| Domain | Ubiquitin-rel_dom | 5.43e-03 | 184 | 162 | 6 | IPR029071 | |
| Domain | RanBD | 5.48e-03 | 13 | 162 | 2 | SM00160 | |
| Domain | Ran_bind_dom | 5.48e-03 | 13 | 162 | 2 | IPR000156 | |
| Domain | PX | 6.54e-03 | 44 | 162 | 3 | SM00312 | |
| Domain | SPRY | 6.95e-03 | 87 | 162 | 4 | SM00449 | |
| Domain | P-loop_NTPase | MYH3 CACNB1 KIF1A SMARCAL1 PSMC2 GAL3ST4 DICER1 ABCB1 EHD4 EFTUD2 MDN1 N4BP2 UCKL1 GET3 DLG2 | 7.02e-03 | 848 | 162 | 15 | IPR027417 |
| Domain | PI3/4_kinase_CS | 7.29e-03 | 15 | 162 | 2 | IPR018936 | |
| Domain | - | 8.28e-03 | 16 | 162 | 2 | 1.10.1070.11 | |
| Domain | PI3Kc | 8.28e-03 | 16 | 162 | 2 | SM00146 | |
| Pathway | REACTOME_SYNTHESIS_OF_IP3_AND_IP4_IN_THE_CYTOSOL | 2.34e-06 | 26 | 120 | 5 | M27053 | |
| Pathway | WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY | 2.38e-06 | 46 | 120 | 6 | M48317 | |
| Pathway | REACTOME_SYNTHESIS_OF_IP3_AND_IP4_IN_THE_CYTOSOL | 3.45e-06 | 28 | 120 | 5 | MM14711 | |
| Pathway | WP_PHOSPHOINOSITIDES_METABOLISM | 3.48e-06 | 49 | 120 | 6 | M40046 | |
| Pathway | REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS | 4.68e-06 | 14 | 120 | 4 | M19193 | |
| Pathway | KEGG_INOSITOL_PHOSPHATE_METABOLISM | 6.21e-06 | 54 | 120 | 6 | M3896 | |
| Pathway | WP_GPR40_PATHWAY | 6.34e-06 | 15 | 120 | 4 | M39526 | |
| Pathway | WP_GLYCOGEN_METABOLISM | 9.39e-06 | 34 | 120 | 5 | MM15985 | |
| Pathway | WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION | 2.13e-05 | 40 | 120 | 5 | M39595 | |
| Pathway | KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM | 4.51e-05 | 76 | 120 | 6 | M9052 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GLYCOGEN_DEGRADATION | 4.87e-05 | 9 | 120 | 3 | M47621 | |
| Pathway | REACTOME_INOSITOL_PHOSPHATE_METABOLISM | 5.25e-05 | 48 | 120 | 5 | M26964 | |
| Pathway | REACTOME_INOSITOL_PHOSPHATE_METABOLISM | 5.25e-05 | 48 | 120 | 5 | MM14589 | |
| Pathway | REACTOME_GLYCOGEN_METABOLISM | 5.50e-05 | 25 | 120 | 4 | M27857 | |
| Pathway | PID_BARD1_PATHWAY | 1.01e-04 | 29 | 120 | 4 | M258 | |
| Pathway | REACTOME_ATTENUATION_PHASE | 1.62e-04 | 13 | 120 | 3 | MM14952 | |
| Pathway | WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION | 1.69e-04 | 33 | 120 | 4 | M39745 | |
| Pathway | REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS | 2.04e-04 | 14 | 120 | 3 | MM15391 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 3.65e-04 | 72 | 120 | 5 | M39403 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 3.89e-04 | 73 | 120 | 5 | MM15906 | |
| Pathway | REACTOME_GLYCOGEN_METABOLISM | 4.47e-04 | 18 | 120 | 3 | MM15577 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CXCL12_CXCR4_PKC_ERK_SIGNALING_PATHAWAY | 5.28e-04 | 19 | 120 | 3 | M47596 | |
| Pathway | WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR | 6.29e-04 | 81 | 120 | 5 | M39490 | |
| Pubmed | SART3 RANBP2 HYOU1 KIF1A DSP ANXA6 POLR2A RPS7 PSMC2 SSB DICER1 STAU1 PBRM1 MDN1 SUGP2 MCM3AP PYGB PYGL PRKDC MED12 ZC3HAV1 | 7.01e-12 | 653 | 166 | 21 | 22586326 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | TRPM6 SART3 RANBP2 HYOU1 KIF1A TRIO DSP ANXA6 POLR2A RPS7 SSB DICER1 STAU1 EHD4 EFTUD2 FANCD2 PBRM1 MDN1 PRDX3 PRDX1 DNAJC9 SGO2 PLCG1 PRKDC HSPA1A HNRNPLL HSPA8 ZC3HAV1 | 2.00e-10 | 1425 | 166 | 28 | 30948266 |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | SART3 RANBP2 HYOU1 DSP DCTN2 RPS7 PSMC2 UBA2 EFHD2 PYM1 SSB STAU1 EFTUD2 PHKG2 MDN1 PRDX3 GET3 PRDX1 DNAJC9 PYGL PRKDC ZW10 HSPA1A HSPA8 ZC3HAV1 | 2.62e-10 | 1149 | 166 | 25 | 35446349 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | PRUNE2 SART3 HYOU1 DCTN2 ANXA6 POLR2A RPS7 PSMC2 UBA2 EFHD2 PYM1 SSB EHD4 EFTUD2 FANCD2 PPP2R5E PRDX3 GET3 PRDX1 PYGB PYGL PLCB3 PLCG1 PRKDC ZW10 HSPA1A HSPA8 | 1.51e-09 | 1455 | 166 | 27 | 22863883 |
| Pubmed | SART3 RANBP2 HYOU1 DNAJC16 POLR2A RPS7 PSMC2 SSB STAU1 EFTUD2 MDN1 SUGP2 PRKDC ZW10 HSPA1B MAP2K7 HSPA8 ZC3HAV1 | 1.94e-09 | 638 | 166 | 18 | 33239621 | |
| Pubmed | 2.49e-09 | 5 | 166 | 4 | 17182002 | ||
| Pubmed | SART3 RANBP2 HYOU1 RBBP8 DCTN2 DNAJC16 POLR2A RPS7 PSMC2 NBN EFHD2 SSB DICER1 STAU1 EFTUD2 FANCD2 PPP2R5E PRDX3 PRDX1 DNAJC9 PRKDC HSPA1A HNRNPLL HSPA8 ZC3HAV1 | 5.50e-09 | 1335 | 166 | 25 | 29229926 | |
| Pubmed | SART3 SYNRG CACNB1 RANBP2 SORBS2 TRIO DSP DNAJC16 RPS7 PSD3 PSMC2 PTEN CRIP2 STAU1 SUGP2 PRDX1 PLCB1 PYGB DLG2 HSPA1B HNRNPLL HSPA8 SHISA6 | 5.96e-09 | 1139 | 166 | 23 | 36417873 | |
| Pubmed | SART3 CMTR1 DSP PSMC2 GRB7 SSB IFIT2 DICER1 STAU1 EFTUD2 SUGP2 HSPA1B HNRNPLL HSPA8 ZC3HAV1 | 8.84e-09 | 469 | 166 | 15 | 37314180 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | SYNRG RANBP2 SORBS2 DSP RBBP8 POLR2A TATDN2 UBA2 NBN EFTUD2 FANCD2 MDN1 SUGP2 MSL3 PLCB3 PRKDC HSPA8 ZC3HAV1 | 3.76e-08 | 774 | 166 | 18 | 15302935 |
| Pubmed | 6.19e-08 | 9 | 166 | 4 | 7589147 | ||
| Pubmed | 6.19e-08 | 9 | 166 | 4 | 10501179 | ||
| Pubmed | RANBP2 DSP DCTN2 PSD3 EFTUD2 PBRM1 MDN1 PRKDC HSPA1A HSPA8 MED12 | 8.84e-08 | 272 | 166 | 11 | 31010829 | |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | MYH3 RANBP2 HYOU1 DSP DCTN2 PSMC2 STAU1 MDN1 PRDX1 PYGB PYGL PRKDC ZW10 HSPA1A HSPA1B HSPA8 | 9.80e-08 | 647 | 166 | 16 | 26618866 |
| Pubmed | 1.07e-07 | 3 | 166 | 3 | 23352621 | ||
| Pubmed | 1.07e-07 | 3 | 166 | 3 | 8687404 | ||
| Pubmed | Stored of Hsp72/Hsp73 in germinal vesicle-stage mouse oocytes. | 1.07e-07 | 3 | 166 | 3 | 15129916 | |
| Pubmed | 1.07e-07 | 3 | 166 | 3 | 28025138 | ||
| Pubmed | SART3 DSP RPS7 SSB STAU1 EFTUD2 DNAJC9 HSPA1A HSPA1B HSPA8 ZC3HAV1 | 1.23e-07 | 281 | 166 | 11 | 26725010 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | SART3 RANBP2 DSP GPX8 POLR2A RPS7 PSMC2 STAU1 EHD4 EFTUD2 STK4 MDN1 SUGP2 PIK3C2A MCM3AP PRDX1 PYGB PYGL PLCG1 PRKDC HSPA8 MED12 ZC3HAV1 | 1.36e-07 | 1353 | 166 | 23 | 29467282 |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | SART3 DSP GPX8 DCTN2 ANXA6 RPS7 PSMC2 UBA2 EHD4 EFTUD2 PBRM1 MDN1 GET3 PRDX1 PRKDC HSPA1A HSPA1B HSPA8 | 1.44e-07 | 847 | 166 | 18 | 35235311 |
| Pubmed | DNA damage shifts circadian clock time via Hausp-dependent Cry1 stabilization. | 1.81e-07 | 175 | 166 | 9 | 25756610 | |
| Pubmed | DSP POLR2A RPS7 PSMC2 PYM1 STAU1 EFTUD2 PRDX1 PYGL PRKDC HSPA1A HSPA8 ZC3HAV1 | 2.29e-07 | 441 | 166 | 13 | 31239290 | |
| Pubmed | PPARγ Interaction with UBR5/ATMIN Promotes DNA Repair to Maintain Endothelial Homeostasis. | 2.66e-07 | 90 | 166 | 7 | 30699358 | |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | HYOU1 DCTN2 POLR2A RPS7 EFHD2 SSB STAU1 EFTUD2 SUGP2 PRDX3 PRDX1 DNAJC9 PRKDC HSPA1A HSPA1B HSPA8 | 3.67e-07 | 714 | 166 | 16 | 28302793 |
| Pubmed | RANBP2 DSP RPS7 PSMC2 STAU1 EFTUD2 FANCD2 PRDX3 GET3 PRDX1 PRKDC HSPA1B HSPA8 | 3.97e-07 | 463 | 166 | 13 | 34901782 | |
| Pubmed | Association analysis of heat shock protein 70 gene polymorphisms in schizophrenia. | 4.26e-07 | 4 | 166 | 3 | 18299791 | |
| Pubmed | 4.26e-07 | 4 | 166 | 3 | 18379898 | ||
| Pubmed | Delayed temporal increase of hepatic Hsp70 in ApoE knockout mice after prenatal arsenic exposure. | 4.26e-07 | 4 | 166 | 3 | 22956628 | |
| Pubmed | SYNRG DSP DCTN2 POLR2A PSMC2 NBN EFHD2 NCK1 MTRF1 SUGP2 PRDX1 PRKDC MED12 ZC3HAV1 | 4.45e-07 | 549 | 166 | 14 | 38280479 | |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | SART3 RANBP2 RPS7 NBN SSB PBRM1 MDN1 PRDX3 DNAJC9 PRKDC HSPA1A HSPA8 | 4.81e-07 | 394 | 166 | 12 | 27248496 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | SART3 SYNRG RANBP2 DSP POLR2A PSMC2 NBN PYM1 STAU1 EFTUD2 STK4 SUGP2 PRDX1 PLCG1 PRKDC HSPA1A HSPA8 ZC3HAV1 | 5.95e-07 | 934 | 166 | 18 | 33916271 |
| Pubmed | RANBP2 DSP RBBP8 POLR2A RPS7 NBN APOA2 EFTUD2 FANCD2 PRDX1 SGO2 PYGM PRKDC HSPA1A HSPA8 | 6.23e-07 | 652 | 166 | 15 | 31180492 | |
| Pubmed | 6.27e-07 | 102 | 166 | 7 | 10231032 | ||
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | RANBP2 POLR2A UBA2 EHD4 EFTUD2 PBRM1 MDN1 PRKDC HSPA1A HNRNPLL HSPA8 | 6.43e-07 | 332 | 166 | 11 | 32786267 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | RANBP2 DSP DCTN2 PSMC2 NBN EHD4 EFTUD2 FANCD2 MDN1 PRKDC MAP2K7 HNRNPLL HSPA8 APBB1IP | 8.89e-07 | 582 | 166 | 14 | 20467437 |
| Pubmed | A DnaJ protein, apobec-1-binding protein-2, modulates apolipoprotein B mRNA editing. | 1.06e-06 | 5 | 166 | 3 | 11584023 | |
| Pubmed | Editing-defective tRNA synthetase causes protein misfolding and neurodegeneration. | 1.06e-06 | 5 | 166 | 3 | 16906134 | |
| Pubmed | 1.06e-06 | 5 | 166 | 3 | 11941371 | ||
| Pubmed | SART3 CMTR1 RPS7 SSB IFIT2 EFTUD2 PRDX1 DNAJC9 PRKDC HSPA1A HSPA1B ZC3HAV1 | 1.06e-06 | 425 | 166 | 12 | 21081503 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | SART3 RANBP2 HYOU1 KIF1A GPX8 DNAJC16 PSMC2 UBA2 EFHD2 NCK1 PTEN DICER1 FANCD2 PYGL PLCG1 PRKDC HNRNPLL ZC3HAV1 | 1.08e-06 | 974 | 166 | 18 | 28675297 |
| Pubmed | PTENα and PTENβ promote carcinogenesis through WDR5 and H3K4 trimethylation. | 1.10e-06 | 217 | 166 | 9 | 31685992 | |
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | RANBP2 CMTR1 DSP STAU1 EFTUD2 SUGP2 PRDX3 PRDX1 PRKDC HSPA1A HSPA8 | 1.31e-06 | 357 | 166 | 11 | 37059091 |
| Pubmed | SART3 SORBS2 HYOU1 TRIO DSP DCTN2 PPP1R9A RPS7 PSD3 EFHD2 SSB STAU1 STK4 PPP2R5E SUGP2 PRDX1 PYGB DLG2 HSPA1A CDH2 HSPA1B HSPA8 | 1.40e-06 | 1431 | 166 | 22 | 37142655 | |
| Pubmed | 1.45e-06 | 18 | 166 | 4 | 1979339 | ||
| Pubmed | HYOU1 ERO1B GPX8 DCTN2 DNAJC16 PSMC2 EFHD2 PYM1 NCK1 SSB STAU1 EHD4 EFTUD2 PIK3C2A MCM3AP DNAJC9 ATG4C ZC3HAV1 | 1.73e-06 | 1007 | 166 | 18 | 34597346 | |
| Pubmed | SART3 RANBP2 SMARCAL1 POLR2A UBA2 NBN EFHD2 ACSS2 FANCD2 PBRM1 MDN1 SUGP2 DNAJC9 PYGB PYGL PRKDC HNRNPLL MED12 | 1.91e-06 | 1014 | 166 | 18 | 32416067 | |
| Pubmed | 2.11e-06 | 6 | 166 | 3 | 8739298 | ||
| Pubmed | Phosphorylation and binding partner analysis of the TSC1-TSC2 complex. | 2.11e-06 | 6 | 166 | 3 | 15963462 | |
| Pubmed | 2.11e-06 | 6 | 166 | 3 | 1409582 | ||
| Pubmed | RING finger protein RNF207, a novel regulator of cardiac excitation. | 2.11e-06 | 6 | 166 | 3 | 25281747 | |
| Pubmed | Genetic aspects of the hsp70 multigene family in vertebrates. | 2.11e-06 | 6 | 166 | 3 | 7988674 | |
| Pubmed | 2.11e-06 | 6 | 166 | 3 | 9305631 | ||
| Pubmed | Heat shock factor 2 is activated during mouse heart development. | 2.11e-06 | 6 | 166 | 3 | 11032181 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | RANBP2 HYOU1 DSP ANXA6 POLR2A PPP1R9A DICER1 ABCB1 STAU1 EHD4 EFTUD2 PBRM1 MDN1 SUGP2 PRDX3 GET3 PRDX1 PRKDC | 2.19e-06 | 1024 | 166 | 18 | 24711643 |
| Pubmed | HYOU1 DCTN2 POLR2A RPS7 SSB STAU1 EFTUD2 MDN1 PRDX3 PRDX1 DNAJC9 PRKDC HSPA1B HSPA8 ZC3HAV1 | 2.31e-06 | 725 | 166 | 15 | 27025967 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | RANBP2 HYOU1 DSP DCTN2 ANXA6 RPS7 EFHD2 SSB CRIP2 STAU1 EHD4 EFTUD2 PIK3C2A GET3 DNAJC9 PYGB PYGL PRKDC HSPA1A HSPA8 ZC3HAV1 | 2.51e-06 | 1367 | 166 | 21 | 32687490 |
| Pubmed | SART3 SYNRG HYOU1 GPX8 PYM1 SSB DICER1 SUGP2 PRKDC HSPA1A HSPA1B HSPA8 ZC3HAV1 | 2.53e-06 | 547 | 166 | 13 | 37267103 | |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | RANBP2 KIF1A TRIO DSP POLR2A PSD3 SSB STAU1 WASH6P PBRM1 PLCB1 PLCB3 | 3.35e-06 | 475 | 166 | 12 | 31040226 |
| Pubmed | ABHD17A RANBP2 HYOU1 ANXA6 RPS7 PSMC2 STAU1 EHD4 EFTUD2 MDN1 ERGIC3 ABHD17B PIK3C2A PYGB PRKDC ZW10 HNRNPLL HSPA8 MED12 | 3.47e-06 | 1168 | 166 | 19 | 19946888 | |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | RANBP2 HYOU1 DSP ANXA6 RPS7 SSB EFTUD2 SUGP2 PRDX1 PRKDC HSPA1A HSPA8 | 3.50e-06 | 477 | 166 | 12 | 31300519 |
| Pubmed | RANBP2 DSP DCTN2 DNAJC16 PSMC2 EFTUD2 FANCD2 ERGIC3 GET3 PRDX1 VPS13A PRKDC ZW10 ZC3HAV1 | 3.63e-06 | 657 | 166 | 14 | 36180527 | |
| Pubmed | Control of mRNA decay by heat shock-ubiquitin-proteasome pathway. | 3.69e-06 | 7 | 166 | 3 | 10205060 | |
| Pubmed | JNK and PTEN cooperatively control the development of invasive adenocarcinoma of the prostate. | 3.69e-06 | 7 | 166 | 3 | 22753496 | |
| Pubmed | 3.69e-06 | 7 | 166 | 3 | 12821674 | ||
| Pubmed | Proteomic analysis of NMDA receptor-adhesion protein signaling complexes. | 3.70e-06 | 86 | 166 | 6 | 10862698 | |
| Pubmed | Characterization of the interactome of the human MutL homologues MLH1, PMS1, and PMS2. | 3.96e-06 | 87 | 166 | 6 | 17148452 | |
| Pubmed | HAPSTR1 localizes HUWE1 to the nucleus to limit stress signaling pathways. | RANBP2 GPX8 POLR2A PSMC2 EFTUD2 FANCD2 PHKG2 PPP2R5E PYGL PRKDC HSPA1A HSPA1B HSPA8 | 4.03e-06 | 571 | 166 | 13 | 37167062 |
| Pubmed | 4.13e-06 | 23 | 166 | 4 | 9730685 | ||
| Pubmed | 4.13e-06 | 23 | 166 | 4 | 9278385 | ||
| Pubmed | 4.77e-06 | 331 | 166 | 10 | 29199018 | ||
| Pubmed | 4.94e-06 | 24 | 166 | 4 | 10617616 | ||
| Pubmed | 4.94e-06 | 24 | 166 | 4 | 10843712 | ||
| Pubmed | HYOU1 DSP DCTN2 ANXA6 PSMC2 UBA2 EFHD2 SSB FANCD2 PRDX1 GSTCD PYGB PRKDC HSPA1A HSPA1B HSPA8 | 5.28e-06 | 878 | 166 | 16 | 37223481 | |
| Pubmed | MYH3 RANBP2 MYOT TRIO DSP PPP2R5E PIK3C2A PYGM HSPA1B HSPA8 PLCE1 MYBPC2 | 5.30e-06 | 497 | 166 | 12 | 23414517 | |
| Pubmed | SART3 MYH3 RANBP2 TCERG1L HYOU1 DSP RBBP8 PPP1R9A RPS7 SH3D21 ABCB1 EHD4 MDN1 N4BP2 PRDX1 VPS13A ATG4C DLG2 PRKDC HSPA8 MYBPC2 | 5.71e-06 | 1442 | 166 | 21 | 35575683 | |
| Pubmed | Function and regulation of heat shock factor 2 during mouse embryogenesis. | 5.88e-06 | 8 | 166 | 3 | 9122205 | |
| Pubmed | FANCD2 binds CtIP and regulates DNA-end resection during DNA interstrand crosslink repair. | 5.88e-06 | 8 | 166 | 3 | 24794430 | |
| Pubmed | 6.00e-06 | 267 | 166 | 9 | 33417871 | ||
| Pubmed | RANBP2 HYOU1 ANXA6 UBA2 SSB STAU1 ERGIC3 SUGP2 PRDX1 DNAJC9 PYGL PRKDC ZW10 HSPA1B MAP2K7 HNRNPLL HSPA8 MED12 | 6.10e-06 | 1103 | 166 | 18 | 34189442 | |
| Pubmed | 6.31e-06 | 144 | 166 | 7 | 35681168 | ||
| Pubmed | Derlin-1 promotes ubiquitylation and degradation of the epithelial Na+ channel, ENaC. | 6.69e-06 | 55 | 166 | 5 | 28137758 | |
| Pubmed | Analysis of a lung defect in autophagy-deficient mouse strains. | 6.89e-06 | 26 | 166 | 4 | 24275123 | |
| Pubmed | 8.06e-06 | 27 | 166 | 4 | 20336759 | ||
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | SART3 POLR2A RPS7 PYM1 SSB STAU1 EFTUD2 SUGP2 PRDX1 PRKDC HSPA1A HSPA1B HNRNPLL HSPA8 ZC3HAV1 | 8.35e-06 | 807 | 166 | 15 | 22681889 |
| Pubmed | 8.78e-06 | 9 | 166 | 3 | 21763498 | ||
| Pubmed | SART3 RANBP2 HYOU1 DSP RPS7 PSMC2 SSB CRIP2 STAU1 PRDX1 DNAJC9 PRKDC HSPA1B HSPA8 | 8.89e-06 | 711 | 166 | 14 | 33022573 | |
| Pubmed | Physiological and pathophysiological characteristics of ataxin-3 isoforms. | 9.04e-06 | 281 | 166 | 9 | 30455355 | |
| Pubmed | SART3 HYOU1 ERO1B DCTN2 DNAJC16 PSD3 NBN PYM1 DICER1 STAU1 EHD4 EFTUD2 MDN1 PIK3C2A N4BP2 VPS13A DNAJC9 HSPA1A HSPA1B HSPA8 ZC3HAV1 | 9.10e-06 | 1487 | 166 | 21 | 33957083 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | RANBP2 DSP DCTN2 POLR2A RPS7 PSMC2 SSB EFTUD2 MDN1 ERGIC3 PRDX1 PYGB PYGL PRKDC HSPA1A HSPA1B MAP2K7 HSPA8 MED12 | 9.82e-06 | 1257 | 166 | 19 | 37317656 |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | SART3 SYNRG RANBP2 CMTR1 DCTN2 NBN STAU1 PRDX1 HSPA1A HSPA8 ZC3HAV1 | 1.04e-05 | 444 | 166 | 11 | 34795231 |
| Pubmed | MBD5 and MBD6 stabilize the BAP1 complex and promote BAP1-dependent cancer. | 1.07e-05 | 287 | 166 | 9 | 36180891 | |
| Pubmed | Biochemical Reduction of the Topology of the Diverse WDR76 Protein Interactome. | 1.12e-05 | 219 | 166 | 8 | 31353912 | |
| Pubmed | TRPM6 ANXA6 UBA2 EFTUD2 PYGB PYGL ZW10 HSPA1A HSPA1B ZNF714 HSPA8 | 1.20e-05 | 451 | 166 | 11 | 36168627 | |
| Pubmed | Specific incorporation of heat shock protein 70 family members into primate lentiviral virions. | 1.25e-05 | 10 | 166 | 3 | 11932435 | |
| Pubmed | 1.25e-05 | 10 | 166 | 3 | 12832005 | ||
| Pubmed | 1.25e-05 | 10 | 166 | 3 | 7906708 | ||
| Pubmed | Expression of phospholipase C isozymes by murine B lymphocytes. | 1.25e-05 | 10 | 166 | 3 | 2033248 | |
| Pubmed | 1.25e-05 | 10 | 166 | 3 | 23921388 | ||
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | DSP RPS7 DICER1 EFTUD2 PHKG2 PBRM1 PPP2R5E PIK3C2A N4BP2 PRKDC HSPA1A HSPA8 ZC3HAV1 | 1.33e-05 | 639 | 166 | 13 | 23443559 |
| Interaction | PDGFRB interactions | HYOU1 DNAJC16 GRB7 NCK1 PTEN FANCD2 PDGFD PYGB PYGL PLCG1 PRKDC HSPA1B | 3.56e-07 | 228 | 163 | 12 | int:PDGFRB |
| Interaction | SIRT7 interactions | SART3 RANBP2 HYOU1 KIF1A DSP ANXA6 POLR2A RPS7 PSMC2 SSB DICER1 STAU1 PBRM1 MDN1 SUGP2 MCM3AP PYGB PYGL PRKDC MED12 ZC3HAV1 | 6.46e-07 | 744 | 163 | 21 | int:SIRT7 |
| Interaction | H2AX interactions | RANBP2 MASP1 HYOU1 RBBP8 ANXA6 POLR2A NBN SSB PTEN STAU1 FANCD2 STK4 PBRM1 MDN1 PRDX3 PRKDC HSPA1A ZC3HAV1 | 1.57e-06 | 593 | 163 | 18 | int:H2AX |
| Interaction | DNAJC2 interactions | HYOU1 DCTN2 ANXA6 RPS7 PYM1 PTEN DICER1 STAU1 EFTUD2 HSPA8 ZC3HAV1 | 1.60e-06 | 217 | 163 | 11 | int:DNAJC2 |
| Interaction | MSH6 interactions | HYOU1 GRB7 NBN PTEN DICER1 EFTUD2 FANCD2 PBRM1 PRDX1 PRKDC HSPA1A HSPA8 | 2.20e-06 | 271 | 163 | 12 | int:MSH6 |
| Interaction | NUDT5 interactions | 2.49e-06 | 75 | 163 | 7 | int:NUDT5 | |
| Interaction | BAP1 interactions | SART3 RANBP2 HYOU1 DSP DCTN2 RPS7 PSMC2 UBA2 NBN EFHD2 PYM1 SSB PTEN STAU1 EFTUD2 PHKG2 MDN1 PRDX3 GET3 PRDX1 DNAJC9 PYGL PRKDC ZW10 HSPA1A HSPA8 ZC3HAV1 | 6.81e-06 | 1314 | 163 | 27 | int:BAP1 |
| Interaction | UBR5 interactions | CALR3 DSP DNAJC16 PSMC2 NBN SSB EHD4 EFTUD2 FANCD2 DPPA4 PDGFD PRMT2 PRKDC ATOH1 MAP2K7 HNRNPLL | 7.09e-06 | 533 | 163 | 16 | int:UBR5 |
| Interaction | DHX9 interactions | SART3 RANBP2 CMTR1 POLR2A PSMC2 SSB PTEN DICER1 ABCB1 STAU1 EFTUD2 FANCD2 SUGP2 PLCB1 PRKDC HSPA1A HSPA8 ZC3HAV1 | 7.23e-06 | 662 | 163 | 18 | int:DHX9 |
| Interaction | SSB interactions | SART3 RPS7 UBA2 SSB PTEN STAU1 FAN1 EFTUD2 FANCD2 PRDX3 PLCB3 ATOH1 HSPA1A HSPA8 ZC3HAV1 | 9.53e-06 | 484 | 163 | 15 | int:SSB |
| Interaction | KBTBD4 interactions | RANBP2 DCTN2 POLR2A EFHD2 PTEN SUGP2 PYGM PRKDC HSPA1A HSPA1B HSPA8 ZC3HAV1 | 1.05e-05 | 316 | 163 | 12 | int:KBTBD4 |
| Interaction | HNRNPAB interactions | CMTR1 SSB PTEN IFIT2 STAU1 EFTUD2 FANCD2 MTRF1 N4BP2 PYGB HSPA1A HSPA8 ZC3HAV1 | 1.06e-05 | 371 | 163 | 13 | int:HNRNPAB |
| Interaction | HYOU1 interactions | CALR3 HYOU1 DSP DNAJC16 CCDC39 STAU1 FANCD2 PRDX3 SCNN1A DNAJC9 HSPA1A HSPA8 | 1.09e-05 | 317 | 163 | 12 | int:HYOU1 |
| Interaction | RPL10A interactions | SART3 CMTR1 RPS7 NCK1 SSB PTEN DICER1 STAU1 EFTUD2 FANCD2 PBRM1 DNAJC9 HSPA1A HSPA8 ZC3HAV1 | 1.10e-05 | 490 | 163 | 15 | int:RPL10A |
| Interaction | PRPF19 interactions | CMTR1 SMARCAL1 POLR2A GRB7 SSB PTEN STAU1 EFTUD2 FANCD2 N4BP2 PRKDC HSPA1A HSPA8 MED12 | 1.83e-05 | 450 | 163 | 14 | int:PRPF19 |
| Interaction | DSG1 interactions | 1.94e-05 | 184 | 163 | 9 | int:DSG1 | |
| Interaction | STIP1 interactions | SART3 RANBP2 HYOU1 DNAJC16 POLR2A RPS7 PSMC2 SSB PTEN STAU1 EFTUD2 FANCD2 MDN1 SUGP2 UBE3D PRKDC ZW10 HSPA1A HSPA1B MAP2K7 HSPA8 ZC3HAV1 | 2.09e-05 | 1006 | 163 | 22 | int:STIP1 |
| Interaction | RPL12 interactions | CMTR1 RPS7 GRB7 NCK1 PTEN DICER1 STAU1 EFTUD2 FANCD2 HSPA1A HSPA8 MED12 ZC3HAV1 | 2.47e-05 | 402 | 163 | 13 | int:RPL12 |
| Interaction | RPLP0 interactions | RANBP2 DNAJC16 RPS7 PSMC2 NCK1 SSB PTEN DICER1 STAU1 EFTUD2 FANCD2 PBRM1 SUGP2 PIK3C2A HSPA1A HSPA8 ZC3HAV1 | 2.63e-05 | 660 | 163 | 17 | int:RPLP0 |
| Interaction | SMC3 interactions | POLR2A PSD3 PSMC2 SSB PTEN STAU1 EFTUD2 FANCD2 PBRM1 MDN1 PRKDC HSPA1A HSPA8 | 2.88e-05 | 408 | 163 | 13 | int:SMC3 |
| Interaction | MLH1 interactions | 3.07e-05 | 244 | 163 | 10 | int:MLH1 | |
| Interaction | BRIX1 interactions | SART3 RBBP8 RPS7 UBA2 GRB7 STAU1 EFTUD2 FANCD2 MDN1 DNAJC9 ZC3HAV1 | 3.42e-05 | 300 | 163 | 11 | int:BRIX1 |
| Interaction | PSMB3 interactions | 3.46e-05 | 198 | 163 | 9 | int:PSMB3 | |
| Interaction | RSL1D1 interactions | RPS7 GRB7 SSB PTEN PLEKHD1 STAU1 EFTUD2 FANCD2 CDR2L DPPA4 DNAJC9 HSPA1A HSPA8 ZC3HAV1 | 3.64e-05 | 479 | 163 | 14 | int:RSL1D1 |
| Interaction | SGCG interactions | 3.86e-05 | 24 | 163 | 4 | int:SGCG | |
| Interaction | RANBP2 interactions | RANBP2 ANXA6 UBA2 GRB7 PTEN STAU1 EFTUD2 FANCD2 PRKDC MAP2K7 HSPA8 MYBPC2 | 3.91e-05 | 361 | 163 | 12 | int:RANBP2 |
| Interaction | NOP58 interactions | RPS7 UBA2 SSB PTEN STAU1 EFTUD2 FANCD2 DNAJC9 HSPA1A HSPA8 MED12 | 4.47e-05 | 309 | 163 | 11 | int:NOP58 |
| Interaction | IQCF2 interactions | 4.57e-05 | 25 | 163 | 4 | int:IQCF2 | |
| Interaction | PSMA4 interactions | ERO1B DSP UBD PSMC2 UBA2 CLSTN1 FANCD2 PRDX3 GET3 HSPA1A HSPA8 | 4.61e-05 | 310 | 163 | 11 | int:PSMA4 |
| Interaction | PMS2 interactions | 4.68e-05 | 80 | 163 | 6 | int:PMS2 | |
| Interaction | AXL interactions | HYOU1 DSP MDN1 DNAJC9 PYGB PLCG1 PRKDC HSPA1A HSPA1B MAP2K7 HSPA8 ZC3HAV1 | 4.84e-05 | 369 | 163 | 12 | int:AXL |
| Interaction | PRKDC interactions | RANBP2 DSP RBBP8 NBN PTEN CLSTN1 STAU1 EFTUD2 FANCD2 PHKG2 PRDX1 MSL3 ATG4C PRKDC ATOH1 MAP2K7 HSPA8 | 5.01e-05 | 695 | 163 | 17 | int:PRKDC |
| Interaction | SIRT6 interactions | SART3 RANBP2 DSP POLR2A SSB PTEN DICER1 STAU1 EFTUD2 PBRM1 DNAJC9 SGO2 PRKDC HSPA8 MED12 ZC3HAV1 | 5.23e-05 | 628 | 163 | 16 | int:SIRT6 |
| Interaction | CARS1 interactions | 5.51e-05 | 120 | 163 | 7 | int:CARS1 | |
| Interaction | EEFSEC interactions | 5.66e-05 | 51 | 163 | 5 | int:EEFSEC | |
| Interaction | ANXA4 interactions | 5.66e-05 | 51 | 163 | 5 | int:ANXA4 | |
| Interaction | PTGES3 interactions | RANBP2 CMTR1 KIF1A SMARCAL1 POLR2A EFTUD2 PIK3C2A UCKL1 PYGL PRKDC HSPA1A MAP2K7 PUS7L | 5.82e-05 | 437 | 163 | 13 | int:PTGES3 |
| Interaction | SNX1 interactions | PRUNE2 KLHL10 HYOU1 EFTUD2 FANCD2 PHKG2 SPANXN4 HSPA1A HSPA8 | 5.88e-05 | 212 | 163 | 9 | int:SNX1 |
| Interaction | GSTA2 interactions | 5.98e-05 | 10 | 163 | 3 | int:GSTA2 | |
| Interaction | SEC22B interactions | ERO1B GPX8 DNAJC16 PTEN DICER1 FANCD2 ERGIC3 GET3 MCM3AP ZW10 HSPA1A MAP2K7 | 6.25e-05 | 379 | 163 | 12 | int:SEC22B |
| Interaction | PFKL interactions | 6.32e-05 | 214 | 163 | 9 | int:PFKL | |
| Interaction | TIPRL interactions | 6.44e-05 | 123 | 163 | 7 | int:TIPRL | |
| Interaction | SLX4 interactions | RANBP2 CMTR1 DSP POLR2A NBN STAU1 EFTUD2 FANCD2 MDN1 SUGP2 PRDX3 PRDX1 PRKDC HSPA1A HSPA8 | 6.55e-05 | 572 | 163 | 15 | int:SLX4 |
| Interaction | XRCC5 interactions | HYOU1 CMTR1 POLR2A NBN PTEN STAU1 EFTUD2 FANCD2 DNAJC9 PLCB3 PRKDC HSPA1A ST18 HSPA8 | 7.91e-05 | 515 | 163 | 14 | int:XRCC5 |
| Interaction | COPS5 interactions | SART3 KLHL10 DSP POLR2A RPS7 PSMC2 UBA2 SSB STAU1 EFTUD2 PIK3C2A PRDX3 GET3 PRDX1 DNAJC9 PYGL PLCG1 PRKDC HSPA1A HSPA1B HSPA8 ZC3HAV1 | 8.16e-05 | 1102 | 163 | 22 | int:COPS5 |
| Interaction | WAPL interactions | 8.42e-05 | 173 | 163 | 8 | int:WAPL | |
| Interaction | MEN1 interactions | SART3 CMTR1 RBBP8 DCTN2 SMARCAL1 POLR2A RPS7 NBN SSB EHD4 EFTUD2 FANCD2 PBRM1 MDN1 SUGP2 PRDX3 MCM3AP DNAJC9 HSPA8 MED12 ZC3HAV1 | 8.82e-05 | 1029 | 163 | 21 | int:MEN1 |
| Interaction | RPS26 interactions | PRUNE2 CMTR1 RPS7 PYM1 SSB PTEN EFTUD2 FANCD2 HSPA1A CDH2 HSPA8 | 8.98e-05 | 334 | 163 | 11 | int:RPS26 |
| Interaction | COPE interactions | DNAJC16 SMARCAL1 UBA2 EFTUD2 FANCD2 ERGIC3 SUGP2 PRDX3 PRKDC ZW10 HSPA8 | 8.98e-05 | 334 | 163 | 11 | int:COPE |
| Interaction | RPL13A interactions | SART3 CMTR1 DNAJC16 RPS7 GRB7 SSB PTEN DICER1 STAU1 EFTUD2 FANCD2 ZNF431 HSPA1A HSPA8 ZC3HAV1 | 9.43e-05 | 591 | 163 | 15 | int:RPL13A |
| Interaction | LRRC40 interactions | 9.65e-05 | 91 | 163 | 6 | int:LRRC40 | |
| Interaction | SOCS1 interactions | 9.87e-05 | 177 | 163 | 8 | int:SOCS1 | |
| Interaction | INSIG2 interactions | 9.87e-05 | 177 | 163 | 8 | int:INSIG2 | |
| Interaction | CRKL interactions | 9.93e-05 | 227 | 163 | 9 | int:CRKL | |
| Interaction | TPR interactions | 1.00e-04 | 281 | 163 | 10 | int:TPR | |
| Interaction | FLT1 interactions | 1.07e-04 | 179 | 163 | 8 | int:FLT1 | |
| Interaction | TXNDC5 interactions | 1.13e-04 | 231 | 163 | 9 | int:TXNDC5 | |
| Interaction | MYH6 interactions | 1.16e-04 | 94 | 163 | 6 | int:MYH6 | |
| Interaction | SNW1 interactions | RANBP2 DSP DCTN2 PSMC2 NBN STAU1 EHD4 EFTUD2 FANCD2 MDN1 PRDX1 PRKDC HSPA1A MAP2K7 HNRNPLL HSPA8 APBB1IP | 1.21e-04 | 747 | 163 | 17 | int:SNW1 |
| Interaction | AGO1 interactions | 1.24e-04 | 183 | 163 | 8 | int:AGO1 | |
| Interaction | CLIC4 interactions | 1.33e-04 | 138 | 163 | 7 | int:CLIC4 | |
| Interaction | NPHP4 interactions | 1.33e-04 | 236 | 163 | 9 | int:NPHP4 | |
| Interaction | DNAJA2 interactions | DCTN2 SMARCAL1 PTEN IFIT2 STAU1 EHD4 EFTUD2 FANCD2 PBRM1 PIK3C2A N4BP2 PRKDC HSPA1A HSPA8 | 1.35e-04 | 542 | 163 | 14 | int:DNAJA2 |
| Interaction | AIRE interactions | 1.37e-04 | 97 | 163 | 6 | int:AIRE | |
| Interaction | RAB11A interactions | SYNRG HYOU1 TRIO DCTN2 PSD3 EFHD2 NCK1 CRIP2 ABCB1 STAU1 EHD4 FANCD2 PRDX1 VPS13A EXOC6B PLCG1 HSPA1A ZC3HAV1 | 1.38e-04 | 830 | 163 | 18 | int:RAB11A |
| Interaction | HNRNPUL1 interactions | GRB7 SSB PTEN STAU1 EFTUD2 FANCD2 MTRF1 DNAJC9 PRMT2 HSPA1A ZC3HAV1 | 1.39e-04 | 351 | 163 | 11 | int:HNRNPUL1 |
| Interaction | AHCY interactions | 1.41e-04 | 293 | 163 | 10 | int:AHCY | |
| Interaction | EEF1A1 interactions | RANBP2 DSP UBD RBBP8 POLR2A RPS7 SSB CLIC6 STAU1 EFTUD2 FANCD2 VPS13A PYGB PLCG1 ATOH1 HSPA1A HSPA8 | 1.53e-04 | 762 | 163 | 17 | int:EEF1A1 |
| Interaction | MCM5 interactions | DSP PTEN DICER1 STAU1 EFTUD2 FANCD2 PRDX1 PYGB PYGL PYGM HSPA1A HSPA8 | 1.64e-04 | 420 | 163 | 12 | int:MCM5 |
| Interaction | ARHGAP24 interactions | TRPM6 ANXA6 UBA2 SSB EFTUD2 PRDX3 PYGB PYGL ZW10 HSPA1A HSPA1B ZNF714 HSPA8 | 1.68e-04 | 486 | 163 | 13 | int:ARHGAP24 |
| Interaction | RECQL4 interactions | SART3 RANBP2 HYOU1 RBBP8 DCTN2 DNAJC16 POLR2A RPS7 PSMC2 NBN EFHD2 SSB DICER1 STAU1 EFTUD2 FANCD2 PPP2R5E PRDX3 PRDX1 DNAJC9 PRKDC HSPA1A HNRNPLL HSPA8 ZC3HAV1 | 1.74e-04 | 1412 | 163 | 25 | int:RECQL4 |
| Interaction | MCM2 interactions | RANBP2 HYOU1 DSP POLR2A RPS7 PTEN STAU1 EHD4 EFTUD2 FANCD2 DPPA4 PRDX3 PRDX1 DNAJC9 PYGB PYGL PYGM PRKDC HSPA1A HSPA8 MED12 | 1.75e-04 | 1081 | 163 | 21 | int:MCM2 |
| Interaction | TRIM16L interactions | 1.77e-04 | 14 | 163 | 3 | int:TRIM16L | |
| Interaction | RPL32 interactions | SART3 CMTR1 RBBP8 RPS7 GRB7 PTEN STAU1 EFTUD2 FANCD2 CDH2 ZC3HAV1 | 1.82e-04 | 362 | 163 | 11 | int:RPL32 |
| Interaction | DNAJC7 interactions | HYOU1 DNAJC16 STAU1 EHD4 FANCD2 MDN1 PIK3C2A VPS13A PRKDC HSPA1A HSPA1B HSPA8 | 1.83e-04 | 425 | 163 | 12 | int:DNAJC7 |
| Interaction | BRCA1 interactions | SART3 HYOU1 ERO1B TRIO DSP RBBP8 POLR2A RPS7 PSMC2 TATDN2 NBN SSB STAU1 EFTUD2 FANCD2 MDN1 PRDX1 SGO2 PYGL PRKDC HSPA8 MED12 ZC3HAV1 | 1.84e-04 | 1249 | 163 | 23 | int:BRCA1 |
| Interaction | CRY2 interactions | 1.86e-04 | 194 | 163 | 8 | int:CRY2 | |
| Interaction | RIOK1 interactions | SART3 CMTR1 RPS7 SSB PTEN IFIT2 STAU1 EFTUD2 PRDX1 DNAJC9 PRKDC HSPA1A HSPA1B ZC3HAV1 | 1.97e-04 | 562 | 163 | 14 | int:RIOK1 |
| Interaction | CDC5L interactions | RANBP2 CMTR1 TRIO DSP DCTN2 SMARCAL1 POLR2A PSMC2 NBN STAU1 EHD4 EFTUD2 FANCD2 MDN1 PRKDC MAP2K7 HNRNPLL HSPA8 | 1.99e-04 | 855 | 163 | 18 | int:CDC5L |
| Interaction | RPN2 interactions | MASP1 HYOU1 DNAJC16 PTEN CLSTN1 CRIP2 STAU1 EHD4 EFTUD2 FANCD2 PPP2R5E DNAJC9 PLCB3 HSPA1A HSPA1B HSPA8 ZC3HAV1 | 2.08e-04 | 782 | 163 | 17 | int:RPN2 |
| Interaction | RPL27 interactions | SART3 CMTR1 DNAJC16 RPS7 GRB7 SSB PTEN DICER1 STAU1 EFTUD2 FANCD2 HSPA1A | 2.08e-04 | 431 | 163 | 12 | int:RPL27 |
| Interaction | IGSF10 interactions | 2.20e-04 | 15 | 163 | 3 | int:IGSF10 | |
| Interaction | IER2 interactions | 2.21e-04 | 37 | 163 | 4 | int:IER2 | |
| Interaction | DCLRE1B interactions | 2.21e-04 | 37 | 163 | 4 | int:DCLRE1B | |
| Interaction | UBA6 interactions | 2.22e-04 | 150 | 163 | 7 | int:UBA6 | |
| Interaction | SNCA interactions | SART3 DSP ANXA6 POLR2A SSB CRIP2 EFTUD2 PBRM1 SUGP2 PRDX3 PRDX1 PLCB1 PYGL PLCG1 HSPA1A HSPA8 | 2.36e-04 | 716 | 163 | 16 | int:SNCA |
| Interaction | SEC23A interactions | 2.38e-04 | 255 | 163 | 9 | int:SEC23A | |
| Interaction | MSH2 interactions | 2.40e-04 | 313 | 163 | 10 | int:MSH2 | |
| Interaction | NTRK3 interactions | HYOU1 TRIO DNAJC16 NCK1 EHD4 WASH6P PLCG1 PRKDC CDH2 HSPA1B ZC3HAV1 | 2.41e-04 | 374 | 163 | 11 | int:NTRK3 |
| Interaction | PYGB interactions | 2.41e-04 | 152 | 163 | 7 | int:PYGB | |
| Interaction | H1-0 interactions | 2.45e-04 | 256 | 163 | 9 | int:H1-0 | |
| Interaction | FLNA interactions | RANBP2 SORBS2 MYOT HYOU1 TRIO RPS7 APOA2 PTEN STAU1 EFTUD2 FANCD2 PIK3C2A PRKDC HSPA1A HSPA8 | 2.56e-04 | 648 | 163 | 15 | int:FLNA |
| Interaction | PSMA3 interactions | SART3 HYOU1 KIF1A UBD DCTN2 PSMC2 UBA2 EFTUD2 FANCD2 HSPA1B HNRNPLL HSPA8 | 2.68e-04 | 443 | 163 | 12 | int:PSMA3 |
| Interaction | SAE1 interactions | 2.72e-04 | 155 | 163 | 7 | int:SAE1 | |
| Interaction | ATG4C interactions | 2.72e-04 | 39 | 163 | 4 | int:ATG4C | |
| Interaction | SYNE3 interactions | SYNRG RANBP2 SORBS2 HYOU1 ERO1B DNAJC16 PSMC2 TOGARAM1 PIK3C2A N4BP2 HSPA1B ZC3HAV1 | 2.73e-04 | 444 | 163 | 12 | int:SYNE3 |
| Interaction | SNRPD3 interactions | SART3 POLR2A UBA2 SSB IFIT2 EFTUD2 FANCD2 PRKDC CENATAC HSPA1A HSPA8 | 2.76e-04 | 380 | 163 | 11 | int:SNRPD3 |
| Interaction | UPF1 interactions | CMTR1 POLR2A PYM1 ACSS2 PTEN STAU1 EFTUD2 FANCD2 DPPA4 PRKDC HSPA1A HSPA1B HSPA8 ZC3HAV1 | 2.76e-04 | 581 | 163 | 14 | int:UPF1 |
| Interaction | FBXL6 interactions | SART3 SYNRG HYOU1 GPX8 PYM1 SSB PTEN DICER1 SUGP2 PRKDC HSPA1A HSPA1B HSPA8 ZC3HAV1 | 2.86e-04 | 583 | 163 | 14 | int:FBXL6 |
| Interaction | MATR3 interactions | RANBP2 CMTR1 DCTN2 PTEN IFIT2 STAU1 EFTUD2 FANCD2 SUGP2 PRKDC HSPA1A HSPA1B HSPA8 MED12 ZC3HAV1 | 2.87e-04 | 655 | 163 | 15 | int:MATR3 |
| GeneFamily | Glycogen phosphorylases | 2.13e-07 | 3 | 109 | 3 | 437 | |
| GeneFamily | Heat shock 70kDa proteins | 2.80e-06 | 17 | 109 | 4 | 583 | |
| GeneFamily | Phospholipases|C2 domain containing phospholipases | 4.52e-06 | 19 | 109 | 4 | 832 | |
| GeneFamily | Phospholipases | 1.17e-04 | 42 | 109 | 4 | 467 | |
| GeneFamily | Ring finger proteins|Fanconi anemia complementation groups|Protein phosphatase 1 regulatory subunits|BRCA1 A complex|BRCA1 B complex|BRCA1 C complex | 3.56e-04 | 5 | 109 | 2 | 1336 | |
| GeneFamily | Peptidyl arginine deiminases | 3.56e-04 | 5 | 109 | 2 | 677 | |
| GeneFamily | Chloride intracellular channels | 5.32e-04 | 6 | 109 | 2 | 307 | |
| GeneFamily | Peroxiredoxins | 5.32e-04 | 6 | 109 | 2 | 953 | |
| GeneFamily | Fibronectin type III domain containing|I-set domain containing|Myosin binding proteins | 9.85e-04 | 8 | 109 | 2 | 658 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.56e-03 | 206 | 109 | 6 | 682 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN | 1.59e-05 | 85 | 164 | 6 | M10575 | |
| Coexpression | PUJANA_CHEK2_PCC_NETWORK | SART3 RBBP8 RPS7 PSMC2 TATDN2 UBA2 NBN NCK1 SSB PPP2R5E PRDX3 PRDX1 DNAJC9 PSMC3IP PRKDC HSPA8 | 2.48e-05 | 761 | 164 | 16 | M11961 |
| Coexpression | KRISHNAN_FURIN_TARGETS_UP | 2.79e-05 | 10 | 164 | 3 | MM1243 | |
| Coexpression | MURARO_PANCREAS_BETA_CELL | PRUNE2 RANBP2 ERO1B KIF1A DSP RBBP8 PSD3 NAP1L2 TOGARAM1 PTEN DICER1 PIK3C2A PLCB1 PRMT2 HSPA1A HSPA1B ST18 HSPA8 | 2.84e-05 | 946 | 164 | 18 | M39169 |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.72e-07 | 189 | 166 | 8 | 3b48b0d220cc24d5170713d61fa91f5bb6c21841 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 6.70e-07 | 193 | 166 | 8 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_CTL|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.44e-07 | 199 | 166 | 8 | 54b64f01e7a73a88bd92b6d4e73cccde60396b2d | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal|6m / Sample Type, Dataset, Time_group, and Cell type. | 8.76e-07 | 200 | 166 | 8 | 13ec8afea86e4a10599c924871ba4e325b0a8013 | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-skeletal_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.15e-06 | 174 | 166 | 7 | 4a6e04b4f12b87c15fa1409989cbe32c43736369 | |
| ToppCell | Severe-CD4+_T_activated|Severe / Disease group and Cell class | 4.64e-06 | 177 | 166 | 7 | a08f170f1143fcdd7d0842a54d9b807a4548f8b7 | |
| ToppCell | Severe-CD4+_T_activated|World / Disease group and Cell class | 4.82e-06 | 178 | 166 | 7 | ef6111238703579a34bd6948bd9d4ca6b7e16063 | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_moDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.65e-06 | 187 | 166 | 7 | 0099def970fbc828756fbf853eca2ce77b8cd342 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 6.89e-06 | 188 | 166 | 7 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-T_lymphocytic-mature_NK_T_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.64e-06 | 191 | 166 | 7 | c4a2a8a7b864df282546e6ac53fcb2269cbb3345 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-innate_lymphocytic-mature_NK_T_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.90e-06 | 192 | 166 | 7 | df4741e7684f010445f0224a1fd61aaa4fae02b3 | |
| ToppCell | moderate-Myeloid-Monocyte-derived_Macrophage|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.18e-06 | 193 | 166 | 7 | 22455801194bd8c73c5c397f5eac4f723429c383 | |
| ToppCell | 368C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 8.46e-06 | 194 | 166 | 7 | 58046894446cb250814252a23f60fdd59c114d77 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 8.74e-06 | 195 | 166 | 7 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | COVID-19-Heart-Mito_CM|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.35e-06 | 197 | 166 | 7 | 44e49943d62bfe622b40ad0460093d31540544df | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Deep_Layer|World / Primary Cells by Cluster | 9.35e-06 | 197 | 166 | 7 | 41e823b14697827f657b13adb3afa581bd91a9cb | |
| ToppCell | IPF-Endothelial-VE_Peribronchial|Endothelial / Disease state, Lineage and Cell class | 9.66e-06 | 198 | 166 | 7 | b8bd1ba268480f54451648e01631b615a3401144 | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-GLP2R---L2-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.03e-05 | 200 | 166 | 7 | d92d51021ab6d78e9c8f89f7c150181004dcbcbd | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-GLP2R-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.03e-05 | 200 | 166 | 7 | cbbb9044283ff9ab63bbfc24d7a9f006b1372705 | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-GLP2R|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.03e-05 | 200 | 166 | 7 | a3e36bbeed19431d07bc205f14f4e0f12bd8f730 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.03e-05 | 200 | 166 | 7 | 829978708463a7459fe1041bd90196775bc4b531 | |
| ToppCell | Neuronal-Excitatory-eA(LAMP5_LINC00507)-GLP2R--|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.03e-05 | 200 | 166 | 7 | dc8702e3cb4ac8c1a9849fc8abf8777f12d55b0b | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.63e-05 | 165 | 166 | 6 | 242bdb7654f415391fb8e9bdc06412c7eee9c97e | |
| ToppCell | facs-BAT-Fat-3m-Myeloid|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.63e-05 | 165 | 166 | 6 | 8bdeacbb47948fabae2575689f811a9fad47f779 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.63e-05 | 165 | 166 | 6 | 436ce4bc75e1ba4351c439ccad19f84ad5bcb92f | |
| ToppCell | facs-BAT-Fat-3m-Myeloid-myeloid_cell|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.63e-05 | 165 | 166 | 6 | bfe330751d34813af7540765b490406078c40da7 | |
| ToppCell | 3'_v3-Lung-Myeloid_Mac-Intestinal_macrophages|Lung / Manually curated celltypes from each tissue | 4.15e-05 | 169 | 166 | 6 | 241644823e6f949aaf4c671d4579721d7ef6b0e5 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.29e-05 | 170 | 166 | 6 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 4.29e-05 | 170 | 166 | 6 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c6-VCAN|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.29e-05 | 170 | 166 | 6 | 0f215911b5880eeffeb43230f7eeaf55b612eaf2 | |
| ToppCell | COVID-19-kidney-Distal_Epi_Doublet_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type | 5.20e-05 | 176 | 166 | 6 | 36f77d878a53b30465b0dea8333a3865dba75613 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-skeletal_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.37e-05 | 177 | 166 | 6 | f6ff1b035fa2418f2448c99d81faa927ece93dfa | |
| ToppCell | (1)_Control_(PBS)-(2)_LEPR+_perivascular_cells_and_VE-Cad+_vascular_cells_(mixed)|(1)_Control_(PBS) / Stress and Cell class | 5.37e-05 | 177 | 166 | 6 | d9e5ac5b8949a77e88e8094079167e4cf2c1bbd1 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-skeletal_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.54e-05 | 178 | 166 | 6 | 69f68eeab11b088fcb1f963c92eff0f1cd0e711a | |
| ToppCell | facs|World / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.71e-05 | 179 | 166 | 6 | 8001db3044e8657980e24422377c4fdb0d7b323e | |
| ToppCell | COVID-19-kidney-AQP1+SLC14A1+EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.71e-05 | 179 | 166 | 6 | 1ce8d18f63e8dd2d3db41fbeca4601bd3b305fba | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-Pleural_Mac|normal_Lymph_Node / Location, Cell class and cell subclass | 6.08e-05 | 181 | 166 | 6 | 921e917f83105896ad8918dc134b871708024021 | |
| ToppCell | Children_(3_yrs)-Epithelial-club_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.26e-05 | 182 | 166 | 6 | 215c303df42f13597b2c7a95cb157c6bc7aca9a1 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.26e-05 | 182 | 166 | 6 | c4a7007c864a9455a7e7447e28ccd380878a6a0f | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.26e-05 | 182 | 166 | 6 | c315d820ffad912c014ba5eac6f5fa6de1a94384 | |
| ToppCell | B_cells-ISG-high_B_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 6.46e-05 | 183 | 166 | 6 | dc2b00e920efa1dcc2a6265cd1024e3249c9974f | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 6.65e-05 | 184 | 166 | 6 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | (7)_DC_activated|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 6.65e-05 | 184 | 166 | 6 | b89871a3e36fde6daa68daf116f8c8d587554c0f | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Mesenchymal-skeletal_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.86e-05 | 185 | 166 | 6 | 9245c322aae8bb9065d50dada198a5ee143a3444 | |
| ToppCell | droplet-Heart-4Chambers-21m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.86e-05 | 185 | 166 | 6 | bb5a4cf93534b9bcd0923f314c389d571e91e7f8 | |
| ToppCell | critical-Myeloid-Monocyte-derived_Macrophage|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 7.28e-05 | 187 | 166 | 6 | 72e4aec49ea0c5fe6cee2a1a46369dbc90cd3fad | |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.49e-05 | 188 | 166 | 6 | 4db566f3f708e66730aa9e16f4d73d91dc534177 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 7.49e-05 | 188 | 166 | 6 | 14bc73cf79c79c9f208369fd8d498e5b26e0114d | |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.49e-05 | 188 | 166 | 6 | 6704b92991ad8c0a910e9f36cd33d00bd26dcb8f | |
| ToppCell | COVID-19-Epithelial-Ionocytes|COVID-19 / Condition, Lineage and Cell class | 7.49e-05 | 188 | 166 | 6 | a581cb9528d0febbf3addbb4f6bc140f91a584e6 | |
| ToppCell | 21-Trachea-Epithelial-Neuroendocrine|Trachea / Age, Tissue, Lineage and Cell class | 7.49e-05 | 188 | 166 | 6 | e78d4f7a5d28c77503cb041ff585d13df4c88bd2 | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.72e-05 | 189 | 166 | 6 | 2a5fda73d38bdc23cf47e5335ffd4e086e990245 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-bronchial_smooth_muscle_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.72e-05 | 189 | 166 | 6 | 4dc32b463546bbe7250dddd281b92ad17ec22da1 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-Airway_Smooth_Muscle|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.72e-05 | 189 | 166 | 6 | 0d06bf0d7191d13a1c4f30a7881e7ea1093bfd6f | |
| ToppCell | Fetal_29-31_weeks-Immune-T_lymphocyte-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.94e-05 | 190 | 166 | 6 | 2a8de1cf27a9ebc3825cf9e7a489ecd064dfc7f9 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 7.94e-05 | 190 | 166 | 6 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-intermediate_neuroendocrine|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 7.94e-05 | 190 | 166 | 6 | 5f1863bce9400b7c932f0e4d0e012ec4e8d7e555 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 7.94e-05 | 190 | 166 | 6 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | P07-Mesenchymal-developing_mesenchymal_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 8.18e-05 | 191 | 166 | 6 | ddbc5f97f2aef19be4ad93db4139876c939b848e | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-pro_B_progenitor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 8.18e-05 | 191 | 166 | 6 | 40813c397f533c2f4a6359a77757f736b6d9e07d | |
| ToppCell | facs-Lung-nan-3m-Epithelial-Alveolar_Epithelial_Type_2|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.18e-05 | 191 | 166 | 6 | c06bbad24e4897b2c3b5015e4de02411ebf75367 | |
| ToppCell | facs-Heart-LV-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.18e-05 | 191 | 166 | 6 | 9d7d680da3979e256191b534ebd14c5383e0cf93 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.18e-05 | 191 | 166 | 6 | 97fb4232417a39801e87725755fd16a57c250209 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 8.18e-05 | 191 | 166 | 6 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | facs-Heart-LV-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.18e-05 | 191 | 166 | 6 | 543da1197c7e62f2c9cbd4a51414bbaaa6d1a92f | |
| ToppCell | facs-Lung-nan-3m-Epithelial-type_II_pneumocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.18e-05 | 191 | 166 | 6 | 5f43f98cfe7a08d61ed55f34808fabfe47f1ac2e | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.18e-05 | 191 | 166 | 6 | 64070a309d7e3f6001272409ab9ce206d0e7d73f | |
| ToppCell | 3'-Broncho-tracheal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_acinar_cell-SMG_duct|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.41e-05 | 192 | 166 | 6 | c227ab1914191e839fc39c9adc2080026d4b04fc | |
| ToppCell | 3'-Broncho-tracheal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_acinar_cell-SMG_duct-SMG_duct_L.0.6.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.41e-05 | 192 | 166 | 6 | bf187a57a559ab732bb815892af45ca922966ac6 | |
| ToppCell | 3'-Broncho-tracheal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_acinar_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.41e-05 | 192 | 166 | 6 | f573b2d205bd4d053a548af3fe3ff9de7be0cd2b | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.41e-05 | 192 | 166 | 6 | 0bf99e029a06151092db1e8a0dcb45f4e688e771 | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.41e-05 | 192 | 166 | 6 | d766221acfce30cbf2c60b3ae40f6744968b952c | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-goblet|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.66e-05 | 193 | 166 | 6 | 402aad2f9e789ad1f2e1536cdc9ce61de7625427 | |
| ToppCell | facs-Lung-24m-Epithelial-alveolar_epithelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.66e-05 | 193 | 166 | 6 | 4a1b4a2faf741ffba5c84218af4df6a8b2a9f4de | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 8.66e-05 | 193 | 166 | 6 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Epithelial-goblet-Goblet_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.66e-05 | 193 | 166 | 6 | 7ee3b1ef5c455f321b4e154ae62c69543fe9b30e | |
| ToppCell | facs-Lung-24m-Epithelial-alveolar_epithelial-type_II_pneumocyte|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.66e-05 | 193 | 166 | 6 | 68adc680deb2f1a29d3cca19c13b9f6271dd4d60 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.66e-05 | 193 | 166 | 6 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | facs-Lung-24m-Epithelial-alveolar_epithelial-type_II_pneumocyte-type_2_alveolar_epithelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.66e-05 | 193 | 166 | 6 | 819e6ee2ffa3e31bf9a2d57c99d9e3eac7072765 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-goblet|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.91e-05 | 194 | 166 | 6 | fb935df966c451e659b8bde281f8aebcb632f6cf | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 8.91e-05 | 194 | 166 | 6 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Epithelial-goblet-Goblet_cell|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.91e-05 | 194 | 166 | 6 | 49cc5f5de4380302100e8cd937f08abe317ac75e | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_NK-natural_killer_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 8.91e-05 | 194 | 166 | 6 | a3a81638b55cb5fc08fe83c8b88f68d49b87e6cb | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_NK-natural_killer_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 8.91e-05 | 194 | 166 | 6 | 0abca32c3547a45cebab0bd69c1f7a0002deaa80 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_NK|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 9.16e-05 | 195 | 166 | 6 | ed41e709523cc3b86b1090d4fc0938ed47cb1fc9 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-goblet-Goblet_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.16e-05 | 195 | 166 | 6 | 219c5d0cde7f6082755154f54db221413ec555cb | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.16e-05 | 195 | 166 | 6 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 9.16e-05 | 195 | 166 | 6 | 609732e83ab7fc3ba7dace66f5a17e46557fd6d1 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-goblet|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.16e-05 | 195 | 166 | 6 | c5f33b420c9ac14dc67fea632b8c2bc2442cbf3d | |
| ToppCell | T/NK_cells-CD8+_Naive_T_cell|World / Lineage and Cell class | 9.16e-05 | 195 | 166 | 6 | 43f11068beea076e9caeb1572215c3f65c9308e1 | |
| ToppCell | facs-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.16e-05 | 195 | 166 | 6 | bd8e24dd598990204998d1dd853ba7a53dc0107e | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.16e-05 | 195 | 166 | 6 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.42e-05 | 196 | 166 | 6 | 2aa1acea3cefb3dbe3afdb04875c96b927e9d860 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.42e-05 | 196 | 166 | 6 | 59ca204c96149fdff08bc524cfa832a30e60e8a4 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-F_2|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.42e-05 | 196 | 166 | 6 | ea8eceacc5d5e1a22b77c31e7c45985dc7bb15de | |
| ToppCell | 3'-Child09-12-SmallIntestine-Endothelial-blood_vessel_EC|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.42e-05 | 196 | 166 | 6 | a0ba408b802fa6d6e42e6d234b6879fdb1583f81 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Mesenchymal|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.42e-05 | 196 | 166 | 6 | d06a29775a41223e02728615af519a18f7e82e8b | |
| ToppCell | 368C|World / Donor, Lineage, Cell class and subclass (all cells) | 9.69e-05 | 197 | 166 | 6 | f41211923938e5d7bfe6bf24f604ab386f17ef10 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.69e-05 | 197 | 166 | 6 | 7e93a97b5ac5ae2f77a4b3141082a1463fed00dd | |
| ToppCell | ILEUM-inflamed-(5)_Plasma-(5)_IgG_plasma_cells|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 9.69e-05 | 197 | 166 | 6 | 6b0941883e40bd82c65659b97a4752e8e32ac190 | |
| Drug | 3,5-dimethylphenyl isocyanate | 3.54e-07 | 3 | 162 | 3 | CID000521488 | |
| Drug | 5'-deoxy-5'-fluoro-5'-(methylthio)adenosine | 3.54e-07 | 3 | 162 | 3 | CID000147839 | |
| Drug | NSC758405 | 3.54e-07 | 3 | 162 | 3 | CID000003201 | |
| Drug | 3,5-dinitrophenyl phosphate | 3.54e-07 | 3 | 162 | 3 | CID000151920 | |
| Drug | pyridoxal phosphoglucose | 3.54e-07 | 3 | 162 | 3 | CID000196007 | |
| Drug | 5-ethyl-4-hydroxy-2-methyl-3(2H)-furanone | 3.54e-07 | 3 | 162 | 3 | CID000093111 | |
| Drug | adenosine-5'-chloromethylphosphonate | 3.54e-07 | 3 | 162 | 3 | CID000191554 | |
| Drug | hydan | 3.54e-07 | 3 | 162 | 3 | CID000008360 | |
| Drug | EHMF | 3.54e-07 | 3 | 162 | 3 | CID000033931 | |
| Drug | pyridoxal 5'-methylenephosphonate | 3.54e-07 | 3 | 162 | 3 | CID003082249 | |
| Drug | Plp 5'-mpa | 3.54e-07 | 3 | 162 | 3 | CID003082151 | |
| Drug | glucose-1,2-cyclic phosphate | 3.54e-07 | 3 | 162 | 3 | CID000191723 | |
| Drug | 3'-FFdUrd | 3.54e-07 | 3 | 162 | 3 | CID000072260 | |
| Drug | 2',3',4',5,5'-pentachloro-2-biphenylol | 3.54e-07 | 3 | 162 | 3 | CID000119518 | |
| Drug | AC1L8XK3 | 3.54e-07 | 3 | 162 | 3 | CID000409735 | |
| Drug | N-acetyl-N'-beta-D-glucopyranosyl urea | 3.54e-07 | 3 | 162 | 3 | CID000446801 | |
| Drug | riboflavin tetraacetate | 3.54e-07 | 3 | 162 | 3 | CID000094186 | |
| Drug | 2,5-dimethyl-3-furanone | 3.54e-07 | 3 | 162 | 3 | CID000085730 | |
| Drug | 3,5-dinitrophenol | 3.54e-07 | 3 | 162 | 3 | CID000011459 | |
| Drug | 8-azidoadenosine 5'-monophosphate | 5.02e-07 | 10 | 162 | 4 | CID000124726 | |
| Drug | galocitabine | 1.41e-06 | 4 | 162 | 3 | CID000065950 | |
| Drug | 5-deoxyribose-1-phosphate | 1.41e-06 | 4 | 162 | 3 | CID000135786 | |
| Drug | ingliforib | 1.41e-06 | 4 | 162 | 3 | CID006451325 | |
| Drug | uric acid riboside | 1.41e-06 | 4 | 162 | 3 | CID000164933 | |
| Drug | pseudo-dl-glucose | 1.41e-06 | 4 | 162 | 3 | CID000125259 | |
| Drug | pyridoxal diphosphate | 1.41e-06 | 4 | 162 | 3 | CID000125696 | |
| Drug | 2,5-anhydro-D-mannitol 1-phosphate | 1.41e-06 | 4 | 162 | 3 | CID000189134 | |
| Drug | AC1LAMW2 | 1.41e-06 | 4 | 162 | 3 | CID000491364 | |
| Drug | FdUrd-C8 | 1.41e-06 | 4 | 162 | 3 | CID000094262 | |
| Drug | Mem-CC | 1.41e-06 | 4 | 162 | 3 | CID003081269 | |
| Drug | BCIp4A | 1.41e-06 | 4 | 162 | 3 | CID000192417 | |
| Drug | 3'-chloromethotrexate | 1.41e-06 | 4 | 162 | 3 | CID000097703 | |
| Drug | heptulose-2-P | 3.50e-06 | 5 | 162 | 3 | CID000124823 | |
| Drug | 6-FPLP | 3.50e-06 | 5 | 162 | 3 | CID000146246 | |
| Drug | gluconohydroximo-1,5-lactone | 3.50e-06 | 5 | 162 | 3 | CID009576855 | |
| Drug | DHPBU | 3.50e-06 | 5 | 162 | 3 | CID000125914 | |
| Drug | 5'-isobutylthioinosine | 3.50e-06 | 5 | 162 | 3 | CID003080910 | |
| Drug | indirubin-5-sulphonate | 3.50e-06 | 5 | 162 | 3 | CID005288641 | |
| Drug | AC1LCUXJ | 3.50e-06 | 5 | 162 | 3 | CID000656425 | |
| Drug | 6-amino-5-bromouracil | 3.50e-06 | 5 | 162 | 3 | CID000080578 | |
| Drug | etafenone | 3.50e-06 | 5 | 162 | 3 | CID000003275 | |
| Drug | ddEtUrd | 3.50e-06 | 5 | 162 | 3 | CID000451452 | |
| Drug | 5-trifluoromethyl-2'-deoxycytidine | 3.50e-06 | 5 | 162 | 3 | CID000125618 | |
| Drug | m-anisidine | 3.50e-06 | 5 | 162 | 3 | CID000010824 | |
| Drug | 2-hydroxypropylphosphonate | 3.50e-06 | 5 | 162 | 3 | CID000441028 | |
| Drug | 6-FDPL | 3.50e-06 | 5 | 162 | 3 | CID000129578 | |
| Drug | 3'-O-methylpyridoxal 5'-phosphate | 3.50e-06 | 5 | 162 | 3 | CID003082179 | |
| Drug | GlcMan | 3.50e-06 | 5 | 162 | 3 | CID000152120 | |
| Drug | U66985 | 3.50e-06 | 5 | 162 | 3 | CID000127224 | |
| Drug | AC1O3M08 | 3.50e-06 | 5 | 162 | 3 | CID006331955 | |
| Drug | Lyndiol | 4.04e-06 | 34 | 162 | 5 | CID000082149 | |
| Drug | butylethanolamine | 4.20e-06 | 16 | 162 | 4 | CID000249006 | |
| Drug | CV-araU | 6.96e-06 | 6 | 162 | 3 | CID006441877 | |
| Drug | 2-thiothymidine | 6.96e-06 | 6 | 162 | 3 | CID003005944 | |
| Drug | Carbocyclic Bvdc | 6.96e-06 | 6 | 162 | 3 | CID006438602 | |
| Drug | 2,2-dimethyl-3-hydroxybutyric acid | 6.96e-06 | 6 | 162 | 3 | CID000152984 | |
| Drug | EdUMP | 6.96e-06 | 6 | 162 | 3 | CID003085112 | |
| Drug | 4-hydroxyacetophenone | 6.96e-06 | 6 | 162 | 3 | ctd:C031335 | |
| Drug | 5'-deoxy-5'-chloroformycin | 6.96e-06 | 6 | 162 | 3 | CID000126430 | |
| Drug | 5-n-propylthioadenosine | 6.96e-06 | 6 | 162 | 3 | CID000656428 | |
| Drug | AzddCyd | 6.96e-06 | 6 | 162 | 3 | CID000451374 | |
| Drug | 5-Ffdru | 6.96e-06 | 6 | 162 | 3 | CID000065561 | |
| Drug | Carbocyclic Ivdu | 6.96e-06 | 6 | 162 | 3 | CID006439191 | |
| Drug | DNPP | 6.96e-06 | 6 | 162 | 3 | CID000067056 | |
| Drug | 5-chloro-indole-2-carboxylic acid | 6.96e-06 | 6 | 162 | 3 | CID000082693 | |
| Drug | SKF83742 | 6.96e-06 | 6 | 162 | 3 | CID000130828 | |
| Drug | NSC-97433 | 6.96e-06 | 6 | 162 | 3 | CID000001803 | |
| Drug | AR-L57 | 6.96e-06 | 6 | 162 | 3 | CID000156890 | |
| Drug | 1-GlcNAc | 6.99e-06 | 18 | 162 | 4 | CID000151446 | |
| Drug | artemether | 1.09e-05 | 20 | 162 | 4 | CID000068911 | |
| Drug | alpha-(fluoromethyl)dehydroornithine | 1.21e-05 | 7 | 162 | 3 | CID006439607 | |
| Drug | 6-fluoropyridoxal | 1.21e-05 | 7 | 162 | 3 | CID003080803 | |
| Drug | 3-methylcytidine | 1.21e-05 | 7 | 162 | 3 | CID000159649 | |
| Drug | AC1L3372 | 1.21e-05 | 7 | 162 | 3 | CID000108025 | |
| Drug | 1 Gpt | 1.21e-05 | 7 | 162 | 3 | CID000101247 | |
| Drug | formycins | 1.21e-05 | 7 | 162 | 3 | CID000512867 | |
| Drug | 5'-methylthioinosine | 1.21e-05 | 7 | 162 | 3 | CID000161214 | |
| Drug | hydantocidin | 1.21e-05 | 7 | 162 | 3 | CID000125429 | |
| Drug | 2',3'-dideoxy-3'-fluorocytidine | 1.21e-05 | 7 | 162 | 3 | CID000356019 | |
| Drug | heptenitol | 1.21e-05 | 7 | 162 | 3 | CID000188267 | |
| Drug | Promonta | 1.21e-05 | 7 | 162 | 3 | CID000108494 | |
| Drug | I0329 | 1.34e-05 | 21 | 162 | 4 | CID000439668 | |
| Drug | spermidine | 1.42e-05 | 253 | 162 | 10 | CID000001102 | |
| Drug | 6-methylpurine | 1.93e-05 | 8 | 162 | 3 | CID005287547 | |
| Drug | Etafenone [inn] | 1.93e-05 | 8 | 162 | 3 | CID000066659 | |
| Drug | AC1NUVX5 | 1.93e-05 | 8 | 162 | 3 | CID005461894 | |
| Drug | amorphin | 1.93e-05 | 8 | 162 | 3 | CID000122792 | |
| Drug | amiodarone | 1.97e-05 | 160 | 162 | 8 | CID000002156 | |
| Drug | pyrazole | 2.28e-05 | 213 | 162 | 9 | ctd:C031280 | |
| Drug | 6-methoxypurine arabinoside | 2.35e-05 | 24 | 162 | 4 | CID000124757 | |
| Drug | Diquat | 2.46e-05 | 165 | 162 | 8 | ctd:D004178 | |
| Drug | alpha-maltosyl fluoride | 2.88e-05 | 9 | 162 | 3 | CID000194237 | |
| Drug | 6-benzyl-2-thiouracil | 2.88e-05 | 9 | 162 | 3 | CID000685814 | |
| Drug | 5'-methylthiotubercidin | 2.88e-05 | 9 | 162 | 3 | CID000188350 | |
| Drug | 5-Iodoribose 1-phosphate | 2.88e-05 | 9 | 162 | 3 | CID003035973 | |
| Drug | 5'-iodo-5'-deoxyadenosine | 2.88e-05 | 9 | 162 | 3 | CID000107502 | |
| Drug | chlorphentermine | 3.27e-05 | 26 | 162 | 4 | CID000010007 | |
| Drug | 4-hydroxynonenal | MYOT HYOU1 PSMC2 NCK1 GSTA2 GSTA3 GSTCD PLCB1 PLCB3 PLCG1 PRKDC CDH2 PLCE1 | 3.41e-05 | 471 | 162 | 13 | CID000001693 |
| Drug | AC1Q6S45 | 3.81e-05 | 27 | 162 | 4 | CID000000508 | |
| Drug | papaverine | 3.91e-05 | 176 | 162 | 8 | CID000004680 | |
| Disease | graft-versus-host disease (biomarker_via_orthology) | 1.52e-06 | 5 | 159 | 3 | DOID:0081267 (biomarker_via_orthology) | |
| Disease | Glycogen Storage Disease | 1.29e-05 | 27 | 159 | 4 | C0017919 | |
| Disease | Malignant neoplasm of breast | UBD SMARCAL1 RPS7 EFCAB13 GRB7 NBN PTEN PLEKHD1 ABCB1 PBRM1 N4BP2 PLCB1 CDH2 HSPA1B MAP2K7 MED12 PADI3 | 7.31e-05 | 1074 | 159 | 17 | C0006142 |
| Disease | Breast Carcinoma | UBD RPS7 GRB7 PTEN PLEKHD1 ABCB1 PBRM1 CDH2 HSPA1B MAP2K7 MED12 | 1.71e-04 | 538 | 159 | 11 | C0678222 |
| Disease | synucleinopathy (biomarker_via_orthology) | 1.72e-04 | 4 | 159 | 2 | DOID:0050890 (biomarker_via_orthology) | |
| Disease | complement C4b measurement | 3.24e-04 | 25 | 159 | 3 | EFO_0008092 | |
| Disease | entorhinal cortical volume | 4.27e-04 | 6 | 159 | 2 | EFO_0005092 | |
| Disease | t-tau:beta-amyloid 1-42 ratio measurement | 4.51e-04 | 66 | 159 | 4 | EFO_0007708 | |
| Disease | Child Development Disorders, Specific | 5.06e-04 | 29 | 159 | 3 | C0085997 | |
| Disease | Child Development Deviations | 5.06e-04 | 29 | 159 | 3 | C0085996 | |
| Disease | Developmental Disabilities | 5.60e-04 | 30 | 159 | 3 | C0008073 | |
| Disease | Mammary Carcinoma, Human | 5.87e-04 | 525 | 159 | 10 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 5.87e-04 | 525 | 159 | 10 | C1257931 | |
| Disease | suberic acid measurement | 5.95e-04 | 7 | 159 | 2 | EFO_0010534 | |
| Disease | cholesteryl ester 16:2 measurement | 5.95e-04 | 7 | 159 | 2 | EFO_0021435 | |
| Disease | Mammary Neoplasms | 6.04e-04 | 527 | 159 | 10 | C1458155 | |
| Disease | familial hyperlipidemia (is_implicated_in) | 7.91e-04 | 8 | 159 | 2 | DOID:1168 (is_implicated_in) | |
| Disease | Fanconi anemia (implicated_via_orthology) | 7.91e-04 | 8 | 159 | 2 | DOID:13636 (implicated_via_orthology) | |
| Disease | Sudden Cardiac Arrest | 7.91e-04 | 8 | 159 | 2 | C1720824 | |
| Disease | Sudden Cardiac Death | 7.91e-04 | 8 | 159 | 2 | C0085298 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 9.60e-04 | 139 | 159 | 5 | DOID:3908 (is_implicated_in) | |
| Disease | apolipoprotein B measurement | EFCAB13 PSD3 NCK1 GCNT4 ABCB1 SIDT2 PDGFD PYGB ATG4C PLCB3 PLCG1 | 9.78e-04 | 663 | 159 | 11 | EFO_0004615 |
| Disease | familial Mediterranean fever (is_implicated_in) | 1.01e-03 | 9 | 159 | 2 | DOID:2987 (is_implicated_in) | |
| Disease | SPINOCEREBELLAR ATAXIA 17 | 1.01e-03 | 9 | 159 | 2 | C1846707 | |
| Disease | glycogen storage disease (is_implicated_in) | 1.01e-03 | 9 | 159 | 2 | DOID:2747 (is_implicated_in) | |
| Disease | Major depression, single episode | 1.01e-03 | 9 | 159 | 2 | C0024517 | |
| Disease | Glaucoma | 1.01e-03 | 9 | 159 | 2 | C0017601 | |
| Disease | atherosclerosis (is_marker_for) | 1.04e-03 | 37 | 159 | 3 | DOID:1936 (is_marker_for) | |
| Disease | arrhythmogenic right ventricular cardiomyopathy (is_implicated_in) | 1.26e-03 | 10 | 159 | 2 | DOID:0050431 (is_implicated_in) | |
| Disease | Colorectal Carcinoma | CACNB1 CPAMD8 MYOT TCERG1L PTEN LGR5 ABCB1 ERGIC3 PDGFD MCM3AP VPS13A | 1.54e-03 | 702 | 159 | 11 | C0009402 |
| Disease | age at assessment, pelvic organ prolapse | 1.62e-03 | 43 | 159 | 3 | EFO_0004710, EFO_0008007 | |
| Disease | colorectal cancer (is_marker_for) | 1.65e-03 | 157 | 159 | 5 | DOID:9256 (is_marker_for) | |
| Disease | Thyroid carcinoma | 1.73e-03 | 44 | 159 | 3 | C0549473 | |
| Disease | Major Depressive Disorder | 2.10e-03 | 243 | 159 | 6 | C1269683 | |
| Disease | lymphocyte count | SYNRG CALR3 RBBP8 ANXA6 PSD3 NBN NCK1 CLSTN1 PBRM1 MCM3AP PLCB1 HSPA1A HSPA1B HNRNPLL APBB1IP PLCE1 ZC3HAV1 | 2.41e-03 | 1464 | 159 | 17 | EFO_0004587 |
| Disease | Hereditary Breast and Ovarian Cancer Syndrome | 2.52e-03 | 14 | 159 | 2 | C0677776 | |
| Disease | Unipolar Depression | 2.88e-03 | 259 | 159 | 6 | C0041696 | |
| Disease | mannan-binding lectin serine protease 1 measurement | 2.89e-03 | 15 | 159 | 2 | EFO_0008223 | |
| Disease | Rhabdomyosarcoma | 2.89e-03 | 15 | 159 | 2 | C0035412 | |
| Disease | Condition, Preneoplastic | 3.01e-03 | 110 | 159 | 4 | C0282313 | |
| Disease | Precancerous Conditions | 3.01e-03 | 110 | 159 | 4 | C0032927 | |
| Disease | hepatocellular carcinoma (is_implicated_in) | 3.05e-03 | 181 | 159 | 5 | DOID:684 (is_implicated_in) | |
| Disease | Lung Neoplasms | 3.22e-03 | 265 | 159 | 6 | C0024121 | |
| Disease | Liver Cirrhosis, Experimental | PRUNE2 SYNRG UBD GPX8 ENPP2 ABCB1 GSTA2 GSTA3 CROT CLIC2 APBB1IP | 3.27e-03 | 774 | 159 | 11 | C0023893 |
| Disease | acute lymphoblastic leukemia (is_implicated_in) | 3.28e-03 | 55 | 159 | 3 | DOID:9952 (is_implicated_in) | |
| Disease | Malignant neoplasm of lung | 3.28e-03 | 266 | 159 | 6 | C0242379 | |
| Disease | methylcobalamin deficiency type cblE, brain serotonin transporter measurement | 3.29e-03 | 16 | 159 | 2 | EFO_0004569, MONDO_0009354 | |
| Disease | breast cancer (is_marker_for) | 3.35e-03 | 185 | 159 | 5 | DOID:1612 (is_marker_for) | |
| Disease | cancer (implicated_via_orthology) | 3.41e-03 | 268 | 159 | 6 | DOID:162 (implicated_via_orthology) | |
| Disease | Hypertrophic Cardiomyopathy | 3.63e-03 | 57 | 159 | 3 | C0007194 | |
| Disease | Carcinoma, Granular Cell | 3.64e-03 | 116 | 159 | 4 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 3.64e-03 | 116 | 159 | 4 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 3.64e-03 | 116 | 159 | 4 | C0205642 | |
| Disease | Carcinoma, Cribriform | 3.64e-03 | 116 | 159 | 4 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 3.64e-03 | 116 | 159 | 4 | C0205641 | |
| Disease | Adenocarcinoma | 3.64e-03 | 116 | 159 | 4 | C0001418 | |
| Disease | Glycogen storage disease | 3.72e-03 | 17 | 159 | 2 | cv:C0017919 | |
| Disease | major depressive disorder (is_implicated_in) | 3.72e-03 | 17 | 159 | 2 | DOID:1470 (is_implicated_in) | |
| Disease | response to efavirenz, virologic response measurement | 3.81e-03 | 58 | 159 | 3 | EFO_0006904, EFO_0006906 | |
| Disease | adverse effect, response to xenobiotic stimulus | 4.00e-03 | 59 | 159 | 3 | EFO_0009658, GO_0009410 | |
| Disease | refractive error, age at onset, Myopia | 4.01e-03 | 193 | 159 | 5 | EFO_0004847, HP_0000545, MONDO_0004892 | |
| Disease | Feeding difficulties | 4.17e-03 | 18 | 159 | 2 | C0232466 | |
| Disease | Adrenocortical carcinoma | 4.17e-03 | 18 | 159 | 2 | C0206686 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 4.19e-03 | 195 | 159 | 5 | DOID:1574 (implicated_via_orthology) | |
| Disease | intrahepatic cholangiocarcinoma (is_marker_for) | 4.65e-03 | 19 | 159 | 2 | DOID:4928 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FLESQEFQPSIAKKY | 161 | Q16537 | |
| EFQPSIAKKYIDQKF | 166 | Q16537 | |
| LKSLAVKEFFSKPKY | 276 | P55345 | |
| QSQPEYKALFKEIFS | 431 | Q86X02 | |
| KVKSPELQAEAKSYF | 51 | P02652 | |
| VKQKAFVEPYFKGDE | 771 | Q99708 | |
| FKPFSNKGKTLVIQY | 81 | Q96L12 | |
| ITFEPKDFLHIKEKY | 126 | Q02641 | |
| IDSIDNFNTYKIFPK | 46 | Q86YB8 | |
| LFLEKEEKYAVFKNP | 256 | Q7Z5R6 | |
| EIKKATPKKYSQFSA | 136 | A0A1B0GVH6 | |
| YPNQKDFPSTAKEAK | 126 | Q7L190 | |
| KKTYCFDAFPNIEKV | 226 | Q96GS6 | |
| FVYKKDGNFLKLPDT | 36 | Q9Y2C3 | |
| DVNEYAPVFKEKSYK | 156 | O94985 | |
| SIVDKYKVTKFYTAP | 396 | Q9NR19 | |
| IIVNPNAAYDKFKDK | 46 | Q13561 | |
| STKYTKETPFVFKLE | 911 | Q9UPY3 | |
| KIVAKKYRDFEFPSE | 651 | Q96NY7 | |
| KFSSKEKYPLFTFVN | 406 | Q96DT6 | |
| SVKNKPLFFADKLYK | 596 | P08133 | |
| YSFQLSKETEEQKPK | 781 | Q9UFE4 | |
| TFYKETKSPFHEIKN | 196 | Q09MP3 | |
| SINYTFKTPEKAKEK | 2606 | P49792 | |
| FKPNEYFKNELLTKT | 291 | Q9ULW6 | |
| KFLVTESPAKFALYK | 131 | Q86WH2 | |
| TFIKYKVFDAKPSAK | 481 | Q8WVV9 | |
| FKIIDNKPSIDSYSK | 366 | P08183 | |
| FKLKEFSKAEAFFPN | 571 | Q9UM07 | |
| EVFKSDYYNKVPVSK | 1016 | Q86U86 | |
| KKAEFFCQLYKPEIV | 606 | Q9NU22 | |
| AILEGYPKSKKQFFE | 186 | Q9P2W1 | |
| YPKSKKQFFEEVGIE | 191 | Q9P2W1 | |
| IESAKKFVETPGQKY | 161 | P05455 | |
| YKKAPIFTSEQGEKL | 356 | P16333 | |
| KTEFSFKPLENAVFK | 141 | O60318 | |
| QVVYKPQKFFRKVES | 451 | O95786 | |
| YDIKDTNTAFPKKVA | 6441 | Q5CZC0 | |
| EKTKNRYFPAFEKVL | 126 | P09210 | |
| EKTKSRYFPAFEKVL | 126 | Q16772 | |
| DAATTEYVQKKKFPE | 221 | O00757 | |
| PKVQVSYKGETKAFY | 101 | P0DMV9 | |
| FKSDDYFVAKPGFKI | 151 | Q9GZP0 | |
| PYKNCKTDFEVLTKV | 321 | O14733 | |
| FKPIQSKKVGTYKNF | 721 | O00443 | |
| KAYDYFQAKKIPIVS | 341 | A8MUH7 | |
| KLKQFDAYPKTLEDF | 6 | Q9Y282 | |
| QYKKVTSSKFFLPIK | 281 | Q8N5Y2 | |
| KYFCLFKPQKTVEEE | 706 | Q9Y2G8 | |
| YTGVPKAEFKKETFD | 561 | P00488 | |
| KKVPIFSKKEEVFGY | 131 | Q93074 | |
| LENYDFTKFHSLKPK | 366 | Q9H223 | |
| LVPYDFEKFKFKLQN | 16 | O15553 | |
| KKFPFSEFVPKVYNQ | 486 | Q9Y2D4 | |
| EVPVYENKYVKFFKS | 41 | Q9BRP8 | |
| FCSVVSQKDDIKPKY | 51 | A6NLU0 | |
| QLFKTERKKATAFFP | 571 | Q9ULW8 | |
| YKDKLDAKQFPPTVS | 461 | Q96RP7 | |
| AAKEFYQKYDPKDVI | 16 | P15735 | |
| FRKNFAKYELFKSSP | 181 | Q14451 | |
| SDTIKPDVQKSKEYF | 181 | Q06830 | |
| STLVNYIEPVKFKSF | 591 | Q01970 | |
| YIEPVKFKSFEAARK | 596 | Q01970 | |
| YQAAALSKAFKVKPF | 421 | Q9Y4L1 | |
| DYFNSVKRFDPVKKT | 351 | Q6JEL2 | |
| QKLVSKEEKSFPIAY | 121 | Q9P109 | |
| NKSFEVQKYVLPKFE | 216 | Q8IZJ3 | |
| NFVDPVTKKKVSYVQ | 2171 | P15924 | |
| IPSFNNDKKLSKYET | 186 | Q92858 | |
| VPYNKLQVIFKSDFS | 101 | P09871 | |
| YVSPKQFSVKEFYLK | 356 | O15033 | |
| EVPSYNAFVKESKQK | 171 | Q8WXX5 | |
| FGIYLSKPEFKKITE | 556 | Q8IY85 | |
| KIEPSQAKYFFKDQV | 311 | P48740 | |
| YFQKEFSKELTPVAK | 356 | P09913 | |
| RKYVTPSDFDQLKQF | 221 | Q5JVL4 | |
| KFSKVPTKVKGYDNL | 86 | O43681 | |
| KEKFLVTPQDYARFK | 116 | Q86UT8 | |
| FIFSRKFPFYKNKEQ | 636 | Q15700 | |
| KFPFYKNKEQSEQET | 641 | Q15700 | |
| PKVQVSYKGETKAFY | 101 | P0DMV8 | |
| PKCDKTVYFAEKVSS | 6 | P52943 | |
| NPYTEFKEFSRKQIK | 81 | Q96C19 | |
| KPKINSFYAFEVKDA | 41 | Q8TED1 | |
| VDKSKNPDFKVFRYS | 781 | Q15020 | |
| IFFKELNYKTNSESP | 526 | P37088 | |
| NFPKSEQFKKTLSYK | 551 | Q8NEC7 | |
| KRKVQYESSEPADFK | 66 | P19022 | |
| KFSNNAKYDPKAIIA | 396 | Q13822 | |
| PFLVYNKELKTDFIK | 71 | O15247 | |
| FYNKKTKDSTFDLPA | 771 | Q8N1G2 | |
| KTLFEKLPEYFFENK | 151 | Q9BXW9 | |
| KQPKETPKSFSFDYS | 41 | Q12756 | |
| VKYSAKFETKAPFSS | 666 | O75473 | |
| LESVKPFANQEEYKK | 36 | Q9UKG9 | |
| FKVKLYFTKTVEEPS | 341 | P60484 | |
| PKVQVEYKGETKSFY | 101 | P11142 | |
| VKQKISPYFKSNDVV | 121 | Q9Y2M0 | |
| FTQVIFKAKSKYSPE | 136 | O60478 | |
| SEDPKYIINVKQFAK | 106 | P35998 | |
| FCSVVSQKDDIKPKY | 51 | F8VTS6 | |
| TLGYFFKIKEIKSPE | 36 | Q9NWD8 | |
| VYKKLTGKDVNFEFP | 176 | P62081 | |
| KDFPSNSFYVVVVVK | 236 | Q8NBJ9 | |
| TKFRKIYSSSFPKEF | 516 | Q93075 | |
| NFTKYVSVPEKDLEK | 1451 | Q8WUY3 | |
| LQKVKYFVAKEDPSS | 396 | A4FU49 | |
| EFQSEKPKISKFDFL | 1026 | Q9UMZ2 | |
| VFYNGKKFKLQSFEP | 1631 | A0AVI2 | |
| YFTEFLKAVESKKQP | 176 | O60934 | |
| PFVTKKLFSVKDENY | 416 | Q96DL1 | |
| YFISKEKNECRKQPF | 2066 | Q9P212 | |
| YLDAKKENSKFTFKP | 221 | Q9H0K6 | |
| KFKEQQPNTYVGFKE | 26 | Q8WW32 | |
| VFKTLPSKNYDPDTK | 261 | Q9NZC9 | |
| DPKQQKIYDLFQKSF | 876 | Q9NZC9 | |
| KYDPEKDKTNFTVYI | 166 | Q6ZSJ9 | |
| KNKPDFYTKAFRSLS | 1126 | Q562F6 | |
| STGYDPVKLFTKLFK | 246 | Q9UBT2 | |
| FPKATDTSFKNKLYD | 541 | P11055 | |
| KPSPAASKEYFQKVN | 241 | P30048 | |
| FSENVEKSKAYKLNP | 551 | Q8NHU6 | |
| QFFETIFSKKERKPA | 1021 | P0DKV0 | |
| FQSLVPKEKYDKNDV | 171 | O75570 | |
| LPAKAVYDFKAQTSK | 866 | O94875 | |
| SKEQEKFGKVPFDYA | 491 | O60284 | |
| KKTYCFDAFPNIDKI | 206 | Q5VST6 | |
| QVKLVKDSEYPFKAQ | 186 | P43234 | |
| KVSPRTTFKEFAEKY | 531 | Q5VWI1 | |
| TFDANPYDSVKKIKE | 21 | O15205 | |
| TQSKIFPCDKYVKVF | 171 | Q8TF32 | |
| KKPTKNDLVYFENSP | 261 | P09544 | |
| TQSKIFPCDKYIKVF | 111 | Q96N38 | |
| SQKPKLAKALFEYIF | 186 | Q8TAM2 | |
| YVKAEKNVPDLKSTY | 966 | Q96RL7 | |
| QFIRTAQPYKFKEKS | 566 | Q9BX84 | |
| KTIFKDFYELEPHKF | 466 | P11217 | |
| YKDFPKNNKNEFVSL | 506 | O95793 | |
| GPKNYEFLKSKREEF | 646 | Q9Y5W7 | |
| EKKSFETNKYFNIHP | 66 | A6NEE1 | |
| DSYAKEKPFKSIPKF | 236 | Q86VV4 | |
| LKETEKAKYPTLVFY | 41 | Q5MJ08 | |
| PSNKAFEKKFRFDYT | 911 | P24928 | |
| YIKKFPLLENTFKAD | 301 | Q7Z6J8 | |
| AFKFYRKKVFELCPS | 826 | Q8IX01 | |
| CVPTFQFYKKEEKVD | 521 | Q86VQ3 | |
| TEYKVTAQFISKKDP | 26 | Q9NRS6 | |
| FSAFLEKEYKVKINP | 546 | P11216 | |
| SSFPETKAEKYVNKA | 981 | P19174 | |
| YIQPVKFESFEISKK | 546 | Q9NQ66 | |
| NAKKIKYFEGVSPKS | 676 | P78527 | |
| SPKCDKFKTYFKFNL | 331 | Q9UL58 | |
| GVIKQYNKFVKPSFD | 251 | Q9NWZ5 | |
| YSKHKEISSQPKEFF | 781 | Q6R2W3 | |
| AKPSFLEYFEQKEKE | 391 | Q13043 | |
| PQEDFCFLSSKKYKL | 716 | Q7Z2W4 | |
| QTPEEKFDFLFKKYA | 156 | Q8N3L3 | |
| EQFSTYDFIPSAKLK | 681 | Q9Y4F4 | |
| DIYFNPKTRKFTKKA | 346 | Q15029 | |
| FSQFLETEYKVKINP | 546 | P06737 | |
| ATDYEKKPNVFKLKT | 856 | Q9NYI0 | |
| KAIKVFSSAKYPAPE | 66 | Q9NQA3 | |
| FPDDYFKGVSQKAKE | 3011 | O75962 | |
| SKFTEKQKYEYPLIF | 936 | B1ANS9 | |
| EQDFKFFKSLSSPKI | 976 | B1ANS9 | |
| VFAPLSEESKNKKYQ | 696 | O43264 | |
| KFKNTEDITFPSVYI | 71 | Q309B1 | |
| KVYGAIFNIKDKNPF | 26 | Q8WU03 | |
| LVEKFYDPTFKKQLS | 551 | Q9Y3Q0 | |
| IKRNENFPKDYVKFS | 1311 | Q86UW6 | |
| FIYKPQSKKVLEGDS | 351 | Q9UBF9 | |
| IKPSSKYVFENVGKK | 296 | Q14324 | |
| KSTAFQKKLEPAYQV | 361 | Q14896 | |
| KIKFSSAPIKVFNTY | 456 | Q9ULJ8 |